National Institute for Biological Standards and Control (NIBSC), 英國國家標(biāo)準(zhǔn)局，是WHO的國際標(biāo)準(zhǔn)品供應(yīng)商，提供WHO超過90%的國際參考物質(zhì)，NIBSC國際標(biāo)準(zhǔn)品用于體外診斷試劑，藥物，疫苗等領(lǐng)域。

產(chǎn)品型號：
廠商性質(zhì)：經(jīng)銷商
更新時間：2024-09-10
訪問量：605

產(chǎn)品咨詢聯(lián)系我們

產(chǎn)品分類CLASSIFICATION

相關(guān)文章ARTICLES

查看全部

詳細(xì)介紹

品牌	其他品牌	供貨周期	現(xiàn)貨
應(yīng)用領(lǐng)域	綜合

National Institute for Biological Standards and Control (NIBSC), 英國國家標(biāo)準(zhǔn)局，是WHO的國際標(biāo)準(zhǔn)品供應(yīng)商，提供WHO超過90%的國際參考物質(zhì)，NIBSC國際標(biāo)準(zhǔn)品用于體外診斷試劑，藥物，疫苗等領(lǐng)域。

**NIBSC國際標(biāo)準(zhǔn)品**參考物質(zhì)
--更新日期 2024.5.20
Product code	Product Description	Category	Sub-Category
234	IPV ELISA MAbs Type 1, 2 and 3 (Type 1; No: 234)	Vaccines	Yellow Fever
1050	IPV ELISA MAbs Type 1, 2 and 3 (Type 2; No: 1050)	Diagnostics	Immunoglobulins and Immune Sera
100976	pCAGGS-SARS-CoV-2-Spike	Diagnostics	Immunoglobulins and Immune Sera
100976	pCAGGS-SARS-CoV-2-Spike	Diagnostics	Immunoglobulins and Immune Sera
100978	VeroE6/TMPRSS2	Diagnostics	Blood Transfusion and Transplantation
100978	VeroE6/TMPRSS2	Diagnostics	Blood Transfusion and Transplantation
100980	SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020	Diagnostics	Blood Transfusion and Transplantation
100980	SARS-CoV-2 infectious virus (BetaCoV/Australia/VIC01/2020	Vaccines	Clostridium
100985	pCAGGS_SARS-CoV-2_Spike D614G	Vaccines	Enteric disease
100985	pCAGGS_SARS-CoV-2_Spike D614G	Vaccines	Enteric disease
100986	pCAGGS-SARS-CoV-2-Spike Bristol Deletion	Vaccines	Tetanus
100986	pCAGGS-SARS-CoV-2-Spike Bristol Deletion	Diagnostics	Immunoglobulins and Immune Sera
100987	Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020	Diagnostics	Immunoglobulins and Immune Sera
100987	Inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020	Vaccines	Diphtheria
100988	Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020	Vaccines	Staphylococcal Immune Sera
100988	Nucleic acid extracts from inactivated SARS-CoV-2 (BetaCoV/Australia/VIC01/2020	Diagnostics	Haemostasis
100989	pCRII-SARS-CoV-2 (5'UTR-NSP2)	Biotherapeutics	Cell Reference Material
100989	pCRII-SARS-CoV-2 (5'UTR-NSP2)	Vaccines	Staphylococcal Immune Sera
100991	pCRII-SARS-CoV-2 (NSP4-NSP8)	Diagnostics	Livestock diseases
100991	pCRII-SARS-CoV-2 (NSP4-NSP8)	Diagnostics	Livestock diseases
100992	pCRII-SARS-CoV-2 (NSP4-NSP8)	Vaccines	Vaccinia
100992	pCRII-SARS-CoV-2 (NSP4-NSP8)	Diagnostics	Livestock diseases
100994	pCRII-SARS-CoV-2 (NSP15-NSP16)	Diagnostics	Livestock diseases
100994	pCRII-SARS-CoV-2 (NSP15-NSP16)	Vaccines	MMR
100996	pCRII-SARS-CoV-2 (ORF3a-ORF6)	Biotherapeutics	Haemostasis
100996	pCRII-SARS-CoV-2 (ORF3a-ORF6)	Biotherapeutics	Haemostasis
100998	SARS-CoV-2 infectious virus (CVR-GLA 1)	Biotherapeutics	Haemostasis
100998	SARS-CoV-2 infectious virus (CVR-GLA 1)	Biotherapeutics	Haemostasis
100999	SARS-CoV-2 infectious virus(CVR-GLA 2)	Diagnostics	Livestock diseases
100999	SARS-CoV-2 infectious virus(CVR-GLA 2)	Vaccines	Pertussis
101000	SARS-CoV-2 infectious virus(CVR-GLA 3)	Vaccines	Tuberculosis (V)
101000	SARS-CoV-2 infectious virus(CVR-GLA 3)	Vaccines	Tuberculosis (V)
101001	VeroE6-ACE2	Vaccines	Clostridium
101001	VeroE6-ACE2	Vaccines	Clostridium
101003	VeroE6-ACE2-TMPRSS2	Vaccines	Livestock diseases
101003	VeroE6-ACE2-TMPRSS2	Diagnostics	Livestock diseases
101004	A549-ACE2-TMPRSS2	Diagnostics	Livestock diseases
101004	A549-ACE2-TMPRSS2	Biotherapeutics	Mouse Embryonic Fibroblasts
101005	A549-ACE2 Clone8	Vaccines	Pertussis
101005	A549-ACE2 Clone8	Vaccines	Pertussis
101006	A549-ACE-2 Clone 8-TMPRSS2	Vaccines	Pertussis
101006	A549-ACE-2 Clone 8-TMPRSS2	Vaccines	Pertussis
101007	SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020	Vaccines	Haemophilus Influenzae type b (Hib)
101007	SARS-CoV-2 Trimeric Spike 50ug (1mg/ml in PBS) Sterile #28.05.2020	Vaccines	Pertussis
101008	HEK293T-ACE2-TMPRSS2	Vaccines	Pertussis
101008	HEK293T-ACE2-TMPRSS2	Diagnostics	Anti-Toxins
101009	Anti-SARS-CoV-2 Nucleocaspid protein (CR3009)	Vaccines	Diphtheria
101009	Anti-SARS-CoV-2 Nucleocaspid protein (CR3009)	Vaccines	Diphtheria
101010	Anti-SARS-CoV-2 Nucleocapsid protein (CR3018)	Vaccines	Clostridium
101010	Anti-SARS-CoV-2 Nucleocapsid protein (CR3018)	Vaccines	Clostridium
101019	VOC-202012/01 (B.1.1.7 lineage) lot 26012021	Vaccines	Clostridium
101019	VOC-202012/01 (B.1.1.7 lineage) lot 26012021	Diagnostics	Livestock diseases
101022	SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4	Diagnostics	Anti-Toxins
101022	SARS-CoV-2 VOC202012/02 (B.1.351 lineage) passage 4	Diagnostics	Livestock diseases
101023	pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021	Vaccines	Botulinum
101023	pl.18SARS-CoV-2-Spike (B.1.1.7) 1ug (100ng/ul) lot #24032021	Diagnostics	Protein Hormones and Endocrine Products
101024	pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021	Diagnostics	Blood Transfusion and Transplantation
101024	pl. 18SARS-CoV-2-Spike (B.1.351) 1ug (100ng/ul) lot #24032021	Vaccines	Influenza
101025	4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2	Vaccines	Influenza
101025	4% formaldehyde inactivated SARS CoV-2 BetaCoV/Australia/VIC01/2020 from VeroE6/TMPRSS2	Diagnostics	Blood Borne Pathogens
101027	Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021	Diagnostics	Protein Hormones and Endocrine Products
101027	Acid/heat inactivated SARS-CoV-2 (B.1.1.7) lot 17022021	Diagnostics	Blood Borne Pathogens
101029	SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021	Diagnostics	Blood Borne Pathogens
101029	SARS-CoV-2 Alpha (B.1.1.7) Purified RNA extracts lot 20052021	Diagnostics	Protein Hormones and Endocrine Products
101030	SARS-CoV-2 VOC-202104/02 (B.1.617.2 lineage)	Vaccines	Meningococcal Reagents
101030	SARS-CoV-2 VOC-202104/02 (B.1.617.2 lineage)	Diagnostics	Protein Hormones and Endocrine Products
101031	SARS-CoV-2 VOC-21FEB02 (B.1.1.7 lineage + E484K)	Diagnostics	Protein Hormones and Endocrine Products
101031	SARS-CoV-2 VOC-21FEB02 (B.1.1.7 lineage + E484K)	Diagnostics	Blood Borne Pathogens
101032	SARS-CoV-2 Kappa (B.1.617.1 lineage	Diagnostics	Blood Transfusion and Transplantation
101032	SARS-CoV-2 Kappa (B.1.617.1 lineage	Diagnostics	Protein Hormones and Endocrine Products
101033	SARS-CoV-2 Delta (AY.1 sub-lineage)	Diagnostics	Protein Hormones and Endocrine Products
101033	SARS-CoV-2 Delta (AY.1 sub-lineage)	Vaccines	Influenza
101034	SARS-CoV-2 Mu (B.1.621 lineage)	Vaccines	Yellow Fever
101034	SARS-CoV-2 Mu (B.1.621 lineage)	Vaccines	Influenza
101035	Acid/Heat Inactivated SARS-CoV-2 Beta (B.1.351 lineage)	Vaccines	Influenza
101035	Acid/Heat Inactivated SARS-CoV-2 Beta (B.1.351 lineage)	Vaccines	Pertussis
101036	Acid/Heat Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage	Vaccines	Pertussis
101036	Acid/Heat Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage	Vaccines	Pertussis
101038	0.01% Formaldehyde Inactivated SARS-CoV-2 Beta (B.1.351 lineage)	Vaccines	Pertussis
101038	0.01% Formaldehyde Inactivated SARS-CoV-2 Beta (B.1.351 lineage)	Vaccines	Pertussis
101039	0.01% Formaldehyde Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage)	Vaccines	Pertussis
101039	0.01% Formaldehyde Inactivated SARS-CoV-2 Delta (B.1.617.2 lineage)	Vaccines	Pertussis
101042	SARS-CoV-2 Nucleocapsid protein (His tagged)	Vaccines	Pertussis
101042	SARS-CoV-2 Nucleocapsid protein (His tagged)	Vaccines	Pertussis
101043	SARS-CoV-2 Nucleocapsid protein 203/204:RG>KR (His tagged)	Vaccines	Pertussis
101043	SARS-CoV-2 Nucleocapsid protein 203/204:RG>KR (His tagged)	Vaccines	Pertussis
101044	SARS-CoV-2 Omicron (lineage B.1.1.529)	Vaccines	Pertussis
101044	SARS-CoV-2 Omicron (lineage B.1.1.529)	Vaccines	Pertussis
101047	Inactivated (Acetic Acid + Heat)SARS-CoV-2 Omicron (BA.1 sublineage)	Vaccines	Pertussis
101047	Inactivated (Acetic Acid + Heat)SARS-CoV-2 Omicron (BA.1 sublineage)	Vaccines	Pertussis
101054	SARS-CoV-2 Omicron BA.1.1 sublineage lot 28032022	Vaccines	Pertussis
101054	SARS-CoV-2 Omicron BA.1.1 sublineage lot 28032022	Vaccines	Pertussis
101055	SARS-CoV-2 Omicron (BA.2)	Vaccines	Pertussis
101055	SARS-CoV-2 Omicron (BA.2)	Vaccines	Pertussis
101062	HEK293T-ACE2-30F-PLP2	Vaccines	Pertussis
101062	HEK293T-ACE2-30F-PLP2	Vaccines	Pertussis
00/410	MAPREC assay of poliovirus type 1 (Sabin).100 480-A, 525-C DNA(1st International Reference Preparation)	Vaccines	Pertussis
00/416	Low Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)	Vaccines	Pertussis
00/418	MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)	Vaccines	Pertussis
00/418	MAPREC assay of poliovirus type 1 (Sabin) (1st International Standard)	Vaccines	Pertussis
00/422	High Mutant Virus Reference for MAPREC assay of poliovirus type 1 (Sabin)(1st International Reference Preparation)	Vaccines	Pertussis
00/440	Influenza Antiserum A/Singapore/1/57 (H2)	Vaccines	Pertussis
00/440	Influenza Antiserum A/Singapore/1/57 (H2)	Vaccines	Pertussis
00/442	Influenza anti B/Yamanashi/166/98 Serum	Vaccines	Pertussis
00/498	Diphtheria Antitoxin Human IgG	Vaccines	Pertussis
00/500	Botulinum Type A-E Antitoxin, Human Serum	Vaccines	Pertussis
00/542	Influenza anti- A/Chick/Scotland/59 (H5N1) Serum	Vaccines	Pertussis
00/546	Influenza Antigen B/Johannesburg/5/99	Vaccines	Pertussis
00/548	Influenza Antigen A/Singapore/1/57 (H2N2)	Vaccines	Pertussis
00/552	Influenza Antigen A/Duck/Singapore-Q/F119-3/97 (H5N3)	Vaccines	Pertussis
00/556	Influenza anti-B/Johannesburg/5/99/ Serum	Vaccines	Influenza
00/572	Interferon Beta (Human, rDNA, Glycosylated) (3rd International standard)	Vaccines	Influenza
00/574	Interferon Beta SER17 Mutein (Human, rDNA derived)	Vaccines	Influenza
00/576	Interferon Beta (Human, Fibroblast-derived, Glycosylated)	Vaccines	Influenza
007SP	Human Anti-Pneumococcal capsule Reference Serum (1st International Standard)	Biotherapeutics	Cytokines and Growth Factors
01/412	Anti-Meningococcal Immunotype L3,7,9 Monoclonal Antibody	Biotherapeutics	Haemostasis
01/420	Interleukin-17 (Human rDNA derived)(WHO Reference Reagent)	Diagnostics	Haematinics and Haemoglobin
01/450	Influenza anti B/Guangdong/120/2000 Serum	Vaccines	Diphtheria
01/452	Influenza anti A/Panama/2007/99 (H3N2) HA serum	Vaccines	Influenza
01/506	Botulinum type F antitoxin, equine	Vaccines	Influenza
01/508	Botulinum type C antitoxin, equine	Vaccines	Influenza
01/510	Botulinum Antitoxin Equine Type D	Vaccines	Influenza
01/512	Botulinum type G antitoxin, equine	Vaccines	Polio
01/514	Anti-Meningococcal Serosubtype P1.7 Monoclonal Antibody	Biotherapeutics	Protein Hormones and Endocrine Products
01/538	Anti-Meningococcal Serosubtype P1.16 mAb	Diagnostics	Protein Hormones and Endocrine Products
01/546	Influenza Antigen B/Guangdong/120/2000	Diagnostics	Protein Hormones and Endocrine Products
01/600	Anti-Toxoplasma IgG, Human(International Standard)	Biotherapeutics	Protein Hormones and Endocrine Products
01/602	Anti-Parvovirus B19, plasma, human(2nd International Standard)	Vaccines	Diphtheria
01/612	Influenza Virus infectious B/Hawaii/10/01	Vaccines	Influenza
01/614	Influenza Antigen A/New Caledonia/20/99	Biotherapeutics	Blood Transfusion and Transplantation
02/102	Influenza anti A/Panama/2007/99 Serum	Vaccines	Polio
02/144	Anti-Meningococcal Serosubtype P1.15 mAb	Vaccines	Influenza
02/148	Anti-Meningococcal Serosubtype P1.4 mAb	Vaccines	Polio
02/178	Anti-Meningococcal Serosubtype P1.2 mAb	Vaccines	Polio
02/180	Anti-Meningococcal Serotype P2.2a mAb	Vaccines	Influenza
02/182	Anti-Japanese Encephalitis Virus Plasma, Human	Vaccines	Influenza
02/184	Anti-Japanese Encephalitis (Anti-JE) Virus Negative Control Plasma, Human	Diagnostics	Protein Hormones and Endocrine Products
02/210	HIV (antibody), 1st International Reference Panel	Vaccines	Influenza
02/226	IVIG negative control for use with IVIG + anti-D(WHO Reference Reagent)	Vaccines	MMR
02/228	IVIG + anti-D for use with negative control IVIG(WHO Reference Reagent)	Vaccines	Hepatitis A Virus
02/230	Biotinylated Brad-5 (Bio-Brad-5)	Vaccines	Pertussis
02/232	Tetanus Toxoid (Non-Adsorbed)	Biotherapeutics	Cytokines and Growth Factors
02/294	Influenza Antiserum A/chick/Italy/1347/99 (H7N1)	Vaccines	Influenza
02/308	Anti-Meningococcal Serotype P3.4 mAb	Vaccines	Influenza
02/310	Anti-Meningococcal Serotype P3.15 mAb	Vaccines	Influenza
02/318	Botulinum Antitoxin Equine Type E	Biotherapeutics	Cytokines and Growth Factors
02/320	Anti-Meningococcal Serosubtype P1.3 mAb	Vaccines	Influenza
02/336	Influenza Antigen A/New Caledonia/20/99	Biotherapeutics	Cytokines and Growth Factors
02/338	Influenza anti A/Panama/2007/99 Serum	Vaccines	Influenza
02/342	Protein C Plasma, Human(2nd International Standard)	Vaccines	Pertussis
03/104	HTLV-1 (antibody) Monitor Sample	Vaccines	Pertussis
03/110	Influenza anti B/Shangdong/9/97 Serum	Vaccines	Pertussis
03/110	Influenza anti B/Shangdong/9/97 Serum	Biotherapeutics	Haemostasis
03/114	Anti-Meningococcal Serosubtype P1.1 mAb	Vaccines	Pertussis
03/124	Thrombopoietin ( Human rDNA derived)	Diagnostics	Protein Hormones and Endocrine Products
03/142	Anti-Meningococcal Serosubtype P1.14 mAb	Biotherapeutics	Cytokines and Growth Factors
03/148	Keratinocyte growth factor (KGF, FGF-7)(24-163)(1st WHO Reference Reagent)	Vaccines	Influenza
03/150	Keratinocyte Growth Factor (KGF,FGF-7)(1st WHO Reference Reagent)	Vaccines	Influenza
03/152	Anti-HPA-1a (International Standard)	Vaccines	Influenza
03/164	Anti-B minimum potency reference preparation(International Standard)	Biotherapeutics	Protein Hormones and Endocrine Products
03/178	Vitamin B12, Serum Folate and holoTC (International standard)	Biotherapeutics	Protein Hormones and Endocrine Products
03/182	Anti-Meningococcal Serotype P3.21 mAb	Vaccines	Polio
03/188	Anti-A minimum potency reference preparation(International Standard)	Vaccines	Polio
03/190	Anti-HPA-3a(minimum potency)(WHO Reference Reagent)	Biotherapeutics	Cytokines and Growth Factors
03/192	Thyroid-Stimulating Hormone, Recombinant, Human, for Bioassay (1st International standard)	Biotherapeutics	Cytokines and Growth Factors
03/200	Interleukin - 18 (Human rDNA derived)(WHO Reference Reagent)	Biotherapeutics	Protein Hormones and Endocrine Products
03/210	Anti-Meningiococcal Serosubtype P1.6 mAb	Biotherapeutics	Cytokines and Growth Factors
03/212	Influenza anti A/Wyoming/03/03 Serum	Biotherapeutics	Cytokines and Growth Factors
03/220	Influenza Antigen A/Wyoming/03/03	Biotherapeutics	Cytokines and Growth Factors
03/224	Anti-Meningococcal Serosubtype P1.10 mAb	Vaccines	Meningococcal Reagents
03/226	Anti-Meningococcal Serosubtype P1.5 mAb	Vaccines	Meningococcal Reagents
03/228	Protein S, Plasma, Human(2nd International Standard)	Biotherapeutics	Haemostasis
03/236	Anti-Meningococcal Serosubtype P1.13 mAb	Biotherapeutics	Cytokines and Growth Factors
03/242	Influenza anti A/Puerto Rico/8/34 (H1N1) HA Serum	Biotherapeutics	Cytokines and Growth Factors
03/244	Influenza Antiserum A/chick/Germany/N/49	Diagnostics	Protein Hormones and Endocrine Products
03/258	Influenza Antigen A/New Caledonia/20/99 (IVR-116)	Biotherapeutics	Cytokines and Growth Factors
03/262	Hepatitis B Surface Antigen subtype adw2, genotype A (International Reference Panel)	Biotherapeutics	Cytokines and Growth Factors
04/122	Anti-Meningococcal Serosubtype P1.12 mAb	Biotherapeutics	Cytokines and Growth Factors
04/160	Influenza Virus infectious NYMC X-147	Biotherapeutics	Cytokines and Growth Factors
04/166	TNF-related Apoptosis-Inducing Ligand (trail), Human, rDNA-derived(1st WHO Reference Reagent)	Biotherapeutics	Haemostasis
04/170	Influenza Virus infectious A/Wellington/1/2004	Biotherapeutics	Cytokines and Growth Factors
04/172	Influenza Virus infectious IVR-139	Biotherapeutics	Cytokines and Growth Factors
04/176	Plasmodium falciparum DNA for NAT Assays(1st International Standard)	Vaccines	Polio
04/198	Anti-Meningococcal Serotype P3.1 mAb	Diagnostics	Haematinics and Haemoglobin
04/202	Influenza Antigen B/ Jiangsu/10/2003	Vaccines	Influenza
04/224	Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004	Diagnostics	Blood Borne Pathogens
04/228	Influenza anti B/ Neuraminidase Serum	Vaccines	Influenza
04/242	Influenza anti B/Jiangsu/10/2003 HA Serum	Vaccines	Influenza
04/246	Anti-Meningococcal Serogroup W-135 mAb	Vaccines	Polio
04/248	Anti-Meningococcal Serosubtype P1.19 mAb	Biotherapeutics	Cytokines and Growth Factors
04/252	Protein C Concentrate, Human(1st International Standard)	Biotherapeutics	Cytokines and Growth Factors
04/260	Influenza anti A/New Caledonia/20/99 HA Serum	Vaccines	Influenza
04/262	Influenza anti A/New York/55/2004 HA Serum	Vaccines	Influenza
04/264	Influenza Antigen A/New York/55/2004 (H3N2) (NYMC X-157)	Biotherapeutics	Cytokines and Growth Factors
05/102	Influenza Virus infectious NYMC BX-7	Biotherapeutics	Haemostasis
05/106	Anti-HPA-1a minimum potency reagent(2nd WHO Reference reagent)	Biotherapeutics	Cytokines and Growth Factors
05/112	Low Molecular Weight Heparin for Molecular Weight Calibration (2nd International Standard).	Biotherapeutics	Haemostasis
05/130	Prothrombin Mutation G20210A, Human gDNA(1st International Genetic Reference Panel 2005)	Biotherapeutics	Cytokines and Growth Factors
05/134	Anti-human papillomavirus type 16 serum (1st International Standard)	Diagnostics	Protein Hormones and Endocrine Products
05/162	Alpha-1-Antitrypsin, plasma derived(1st International standard)	Biotherapeutics	Cytokines and Growth Factors
05/190	Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody	Vaccines	Pertussis
05/192	Anti Meningococcal Serotype P2.2b Monoclonal Antibody	Vaccines	Influenza
05/234	Influenza Antigen A/Hiroshima/52/2005 (H3N2) (IVR-142)	Vaccines	Influenza
05/236	Influenza anti A/Wisconsin/67/2005 Serum	Vaccines	Influenza
05/252	Influenza anti B Neuraminidase Serum	Vaccines	Influenza
06/108	Influenza Virus infectious IVR-116	Vaccines	Influenza
06/124	Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 2 (1st International Standard)	Biotherapeutics	Cytokines and Growth Factors
06/128	Monoclonal Antibody for Serotyping Bordetella pertussis Fimbrial Antigen 3 (1st International Standard)	Biotherapeutics	Cytokines and Growth Factors
06/140	Pertussis Antiserum(human)1st IS-WHO international Standard.	Biotherapeutics	Cytokines and Growth Factors
06/142	Pertussis Antiserum (Human) 1st WHO Reference Reagent	Vaccines	Influenza
06/164	Influenza Virus infectious 1 VR-142	Biotherapeutics	Cytokines and Growth Factors
06/166	Antithrombin Concentrate, Human (3rd International Standard)	Biotherapeutics	Cytokines and Growth Factors
06/170	Influenza Antigen A/New Caledonia/20/99	Biotherapeutics	Cytokines and Growth Factors
06/192	Influenza anti A/turkey/Turkey/1/05 (NIBRG-23) HA serum(sheepSH465 & SH466)	Vaccines	Influenza
06/202	Human Papillomavirus (HPV) Type 16 DNA (1st International Standard)	Biotherapeutics	Cytokines and Growth Factors
06/206	Human Papillomavirus (HPV) Type 18 DNA (1st International Standard)	Biotherapeutics	Cytokines and Growth Factors
06/242	Influenza Virus Infectious NYMC X-161B (A/Wisconsin/67/2005 HGR)	Biotherapeutics	Cytokines and Growth Factors
0688	SARS CoV-1 spike S1 protein	Diagnostics	Protein Hormones and Endocrine Products
0688	SARS CoV-1 spike S1 protein	Biotherapeutics	Cytokines and Growth Factors
07/102	Influenza Antigen A/Solomon Islands/3/2006 (H1N1)(IVR-145)	Vaccines	Influenza
07/104	Influenza anti A/Solomon Islands/3/2006 (H1N1) (IVR-145) HA Serum	Vaccines	Influenza
07/112	Influenza Antigen A/turkey/Turkey/1/2005 (H5N1) NIBRG-23	Vaccines	Influenza
07/144	Influenza Virus infectious IVR-145,	Vaccines	Influenza
07/146	Influenza anti A/HongKong/1073/99 like (H9) HA Serum (sheep)	Biotherapeutics	Cytokines and Growth Factors
07/148	Influenza anti A/Vietnam/1194/04 (H5N1) HA Serum	Biotherapeutics	Cytokines and Growth Factors
07/150	Human Plasma Anti-Influenza H5N1 (1st International Standard)	Vaccines	Influenza
07/164	Anti-hepatitis B surface antigen(Anti-HBs) immunoglobulin (2nd International Standard)	Vaccines	Influenza
07/184	Influenza anti B/Malaysia/2506/2004-HA Serum	Diagnostics	Haematinics and Haemoglobin
07/202	Recombinant soluble transferrin receptor (rsTfR)(1st WHO Reference Reagent)	Biotherapeutics	Haemostasis
07/216	Diphtheria Toxoid (Adsorbed) (4th International Standard)	Vaccines	MMR
07/222	RhD/SRY Plasma DNA sensitivity standard (1st WHO Reference Reagent)	Biotherapeutics	Cytokines and Growth Factors
07/228	Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard"	Vaccines	Influenza
07/270	BCG Vaccine of Danish 1331 sub-strain (1st WHO Reference Reagent)	Vaccines	Influenza
07/272	BCG Vaccine of Tokyo 172 sub-strain(1st WHO Reference Reagent)	Vaccines	Influenza
07/274	BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent)	Vaccines	Influenza
07/278	Influenza anti A/mallard/Netherlands/12/2000 (H7) HA serum (NIBRG-60) (sheep SH474 AND SH475)	Biotherapeutics	Cytokines and Growth Factors
07/286	Monitor sample for HBsAg 0.05IU/ml	Biotherapeutics	Cytokines and Growth Factors
07/288	Hepatitis B Surface Antigen (HBsAg) British Working Standard 0.2 IU/ml	Biotherapeutics	Protein Hormones and Endocrine Products
07/290	Influenza Antigen A/Anhui/1/05 (H5N1) IBCDC-RG-6	Biotherapeutics	Protein Hormones and Endocrine Products
07/298	Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques	Vaccines	MMR
07/306	Anti-A and anti-B in IVIG: Positive control for haemagglutination tests (WHO Reference Reagent)	Biotherapeutics	Cytokines and Growth Factors
07/316	Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma (6th I.S.)	Biotherapeutics	Cytokines and Growth Factors
07/318	Meningococcal Group C Polysaccharide	Vaccines	Influenza
07/328	Unfractionated Heparin (6th I.S.)	Biotherapeutics	Cytokines and Growth Factors
07/336	Influenza Antigen A/mallard/Netherlands/12/00(H7N3) NIBRG-60	Biotherapeutics	Cytokines and Growth Factors
07/338	Influenza antiserum A/Anhui/1/05 (H5)	Biotherapeutics	Cytokines and Growth Factors
07/348	Influenza Virus infectious NYMC X-171B	Biotherapeutics	Protein Hormones and Endocrine Products
07/350	Blood Coagulation Factor VIII Concentrate (8th I.S.)	Biotherapeutics	Protein Hormones and Endocrine Products
07/358	Influenza Virus infectious NIB-50	Vaccines	Influenza
07/362	Influenza Virus infectious IVR-149	Biotherapeutics	Protein Hormones and Endocrine Products
08/100	Influenza Antigen A/Brisbane/59/2007 (IVR-148) (H1N1)	Biotherapeutics	Cytokines and Growth Factors
08/108	Influenza Virus Infectious NIBRG-91 (H9N2)	Biotherapeutics	Cytokines and Growth Factors
08/126	Influenza Anti N1 Neuraminidase Serum SH485	Biotherapeutics	Cytokines and Growth Factors
08/138號	Influenza Virus Infectious B/Florida/4/2006	Vaccines	Influenza
08/140	Influenza Antigen B/Florida/4/2006	Biotherapeutics	Cytokines and Growth Factors
08/142	Influenza antiserum A/Anhui/1/05 (H5)	Biotherapeutics	Cytokines and Growth Factors
08/154	Influenza Virus Infectious NIBRG-12 (H5N1)	Diagnostics	Immunoglobulins and Immune Sera
08/156	Influenza Virus Infectious NIBRG-23 30060 VE3 (H5N1)	Diagnostics	Blood Borne Pathogens
08/158	Fragile X Syndrome gDNA (1st International Genetic Reference Panel)	Biotherapeutics	Cytokines and Growth Factors
08/160	Haemophilia A, Intron-22 inversion, gDNA, (1st International Genetic Reference Panel)	Vaccines	MMR
08/178	Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques	Biotherapeutics	Cytokines and Growth Factors
08/184	Influenza Antigen B/Malaysia/2506/2004	Vaccines	Pertussis
08/202	Influenza anti A/chick/Hong Kong/G9/1997/(H9) HA serum (NIBRG-94)(H9N1)	Vaccines	Influenza
08/204	Thyroid Stimulating Antibody (2nd I.S.)	Vaccines	Influenza
08/208	Influenza Antigen A/HongKong/1073/99 (H9N2)	Vaccines	Influenza
08/210	Influenza anti A/Cambodia/R0405050/2007 (H5) HA serum (NIBRG-86)	Vaccines	Tetanus
08/216	Influenza Antigen A/Cambodia/RO405050/2007 (H5N1)	Vaccines	Pertussis
08/218	Tetanus Toxoid Adsorbed (4th International Standard)	Diagnostics	Haematinics and Haemoglobin
08/228	Influenza Antigen A/chick/Hong Kong/G9/1997 (H9N2) NIBRG-91	Biotherapeutics	Protein Hormones and Endocrine Products
08/230	Streptodornase (2nd International Standard)	Vaccines	Pertussis
08/246	Influenza anti A/Brisbane/10/2007- like HA serum	Vaccines	Pertussis
08/248	Influenza Virus Infectious NIBRG-107 VE2 30480	Vaccines	Pertussis
08/250	Influenza Virus Infectious NIBRG-63 VE2 30500 (H7N1)	Vaccines	Pertussis
08/252	Influenza Virus Infectious NIBRG-109 VE2 30490	Vaccines	Influenza
08/256	C1- Inhibitor, Concentrate (1st International Standard)	Biotherapeutics	Protein Hormones and Endocrine Products
08/258	Antithrombin, Plasma (3rd International Standard)	Vaccines	Pertussis
08/262	C1 Inhibitor (Plasma)(1st International Standard)	Biotherapeutics	Cytokines and Growth Factors
08/266	Sex Hormone Binding Globulin.(2nd International Standard)	Biotherapeutics	Cytokines and Growth Factors
08/268	Influenza Antigen A/mallard/England/727/2006 (H2N3)NIBRG-107	Biotherapeutics	Cytokines and Growth Factors
08/278	Influenza Antigen A/Brisbane/10/2007-like (Prepared from A/Uruguay/716/2007 (NYMC X-175C))	Biotherapeutics	Cytokines and Growth Factors
08/298	Influenza Virus Infectious B/Brisbane/33/2008 30720 E5	Biotherapeutics	Cytokines and Growth Factors
08/300	Influenza Virus infectious IVR-148	Vaccines	Influenza
08/304	Influenza virus infectious NYMC X-175C	Vaccines	Influenza
08/322	Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing	Vaccines	Influenza
08/324	Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing	Biotherapeutics	Cytokines and Growth Factors
08/356	Influenza antiserum A/Japan/305/57 (H2)	Vaccines	Influenza
08/362	Influenza Antigen A/New York/107/2003 (H7N2)NIBRG-109	Biotherapeutics	Cytokines and Growth Factors
09/100	Influenza anti A/mallard/England/727/2006 (N3) NA serum (NIBRG-107) (Sheep SH503)	Diagnostics	Protein Hormones and Endocrine Products
09/110	Parvovirus B19 DNA Nucleic Acid Amplification Technology(NAT) based assays Genotype Panel(1st International Standard)	Biotherapeutics	Protein Hormones and Endocrine Products
09/130	Influenza Virus Infectious NIBRG-122	Vaccines	Influenza
09/136	Granulocyte Colony Stimulating Factor (Human, rDNA Derived)(2nd International Standard)	Biotherapeutics	Cytokines and Growth Factors
09/138	Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR (1st I.S.)	Vaccines	Pertussis
09/140	Prader Willi & Angelman Syndromes, Human gDNA,(1st International Genetic Reference Panel)	Vaccines	Influenza
09/148	Influenza anti A/New York/107/2003 (H7) HA serum (Sheep SH504 and SH505)	Vaccines	Influenza
09/162	Human Cytomegalovirus (HCMV) for Nucleic Acid Amplification Techniques (1st International Standard)	Diagnostics	Haematinics and Haemoglobin
09/170	Anti-Meningococcal factor H binding protein variant 1 (JAR4) monoclonal antibody	Diagnostics	Haematinics and Haemoglobin
09/172	Blood coagulation Factors II, VII, IX, X Plasma (4th International Standard 2010)	Biotherapeutics	Cytokines and Growth Factors
09/174	Influenza Antigen A/California/7/09 (H1N1)v (NYMCX-179A)(Cell Derived)	Biotherapeutics	Cytokines and Growth Factors
09/182	VWF Factor Concentrate (2nd International Standard)	Vaccines	Influenza
09/184	Influenza Antigen A/Vietnam/1194/2004 (H5N1) NIBRG-14	Vaccines	Influenza
09/186	Chagas (anti-Trypanosoma cruzi II) antibody in human plasma(1st International Standard)	Vaccines	Influenza
09/188	Chagas (anti-Trypanosoma cruzi I) antibody in Human Plasma (1st International Standard)	Biotherapeutics	Protein Hormones and Endocrine Products
09/196	Influenza Antigen A/California/7/09 (H1N1)v (NIBRG-121xp) (Egg Derived)	Biotherapeutics	Cytokines and Growth Factors
09/222	Human anti-Haemophilus influenzae b reference serum	Biotherapeutics	Cytokines and Growth Factors
09/234	Transforming Growth Factor-BETA 3 (Human, rDNA derived TGF-? 3) (1st International Standard)	Biotherapeutics	Cytokines and Growth Factors
09/236	Influenza Virus Infectious IVR-153	Vaccines	Influenza
09/242	Fibrinogen Concentrate (B)(2nd International Standard)	Vaccines	Influenza
09/260	Epstein-Barr Virus for Nucleic Acid Amplification Techniques(1st International Standard)	Vaccines	Influenza
09/264	Fibrinogen Plasma (D)(3rd International Standard)	Vaccines	Influenza
09/266	GLIAL CELL-DERIVED NEUROTROPHIC FACTOR (GDNF), human, rDNA-derived	Biotherapeutics	Cytokines and Growth Factors
09/268	Influenza Virus Infectious NIBRG-121xp	Biotherapeutics	Protein Hormones and Endocrine Products
09/272	Placental growth factor Ala 21 - Arg 149, human, rDNA-derived (PlGF, PlGF-1)	Biotherapeutics	Protein Hormones and Endocrine Products
09/274	Influenza Virus Infectious NYMC X-185	Biotherapeutics	Cytokines and Growth Factors
09/280	Influenza Virus Infectious NIB-64	Biotherapeutics	Protein Hormones and Endocrine Products
09/284	Anti-Human Neutrophil Antibody 1a WHO Reference Reagent	Diagnostics	Haematinics and Haemoglobin
09/296	Pro-Insulin, human (1st International Standard)	Diagnostics	Immunoglobulins and Immune Sera
09/304	Influenza Virus Infectious IVR-155	Diagnostics	Protein Hormones and Endocrine Products
09/308	Influenza Serology Antigen Reagent X-179A (H1N1pdm) for HI Assay	Vaccines	Influenza
09/310	Influenza Antigen A/Wisconsin/15/09 (H3N2) (NYMCX-183)	Vaccines	Influenza
10/104	Reteplase Reference Material	Biotherapeutics	Protein Hormones and Endocrine Products
10/120	Influenza Anti A/Brisbane/59/2007 (IVR 148)(H1N1) HA serum	Diagnostics	Allergen
10/128	Diphtheria Polyclonal Antibody	Vaccines	Influenza
10/130	Diphtheria Monoclonal Antibody	Vaccines	Influenza
10/132	Tetanus Polyclonal Antibody	Vaccines	Influenza
10/134	Tetanus Monoclonal Antibody	Diagnostics	Blood Transfusion and Transplantation
10/140	Anti-human papillomavirus[HPV] 18 serum (1st International Standard)	Biotherapeutics	Protein Hormones and Endocrine Products
10/142	Anti-human leukocyte antigen antibodies (negative plasma)	Diagnostics	Allergen
10/164	Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain].	Vaccines	Influenza
10/164	Oral Poliovaccine Sabin Type 1 reference strain [LS-c, 2ab strain].	Vaccines	Influenza
10/168	Oral Poliovaccine Sabin Type 3 reference	Diagnostics	Protein Hormones and Endocrine Products
10/168	Oral Poliovaccine Sabin Type 3 reference	Diagnostics	Allergen
10/176	Interleukin-29 (Interferon Lambda, Human, rDNA derived) WHO Reference Reagent	Diagnostics	Protein Hormones and Endocrine Products
10/178	Endotoxin (3rd International Standard)	Biotherapeutics	Protein Hormones and Endocrine Products
10/198	Anti-malaria (Plasmodium falciparum) human serum(1st WHO Reference Reagent)	Diagnostics	Protein Hormones and Endocrine Products
10/202	Influenza antibody (Human) to A/California/7/2009 'like' (H1N1v) virus (2nd International Standard)	Vaccines	Influenza
10/214	Influenza Anti N2 Neuraminidase Serum SH395 & SH396	Vaccines	Influenza
10/218	Influenza Anti A/California/7/2009 (N1) NA Serum	Vaccines	Influenza
10/226	Influenza Virus Infectious IVR-158	Biotherapeutics	Protein Hormones and Endocrine Products
10/232	Blood Group Genotyping Reference Reagent RBC1 (OR1R2)(WHO Reference Reagent)	Biotherapeutics	Cytokines and Growth Factors
10/234	Blood Group Genotyping Reference Reagent RBC12 (ODpsi)(WHO Reference Reagent)	Biotherapeutics	Protein Hormones and Endocrine Products
10/236	Blood Group Genotyping Reference Reagent RBC4 (AR1R1)(WHO Reference Reagent)	Biotherapeutics	Haemostasis
10/238	Blood Group Genotyping Reference Reagent RBC5 (Brr)(WHO Reference Reagent)	Biotherapeutics	Haemostasis
10/242	Toxoplasma gondii DNA Nucleic Acid Amplification Techniques(1st International Standard)	Diagnostics	Haematinics and Haemoglobin
10/252	Factor VII Concentrate (2nd International Standard)	Biotherapeutics	Protein Hormones and Endocrine Products
10/258	Influenza Antigen A/California/7/2009-like(NIB-74)	Biotherapeutics	Cytokines and Growth Factors
10/262	Diphtheria Antitoxin Human IgG(1st International Standard)	Vaccines	Polio
10/272	BCG vaccine of Moreau-RJ sub-strain(1st WHO Reference Reagent)	Diagnostics	Allergen
10/286	Follicle Stimulating Hormone, Luteinizing Hormone human, urinary for bioassay(5th International Standard)	Diagnostics	Allergen
11/108	Influenza Virus infectious NYMC X-187	Biotherapeutics	Protein Hormones and Endocrine Products
11/126	Factors II and X Concentrate (4th International standard)	Biotherapeutics	Protein Hormones and Endocrine Products
11/134	Influenza Antigen A/California/7/2009 (H1N1) Like (A/Brisbane/10/2010- cell derived)	Diagnostics	Protein Hormones and Endocrine Products
11/170	Erythropoietin, recombinant, for Bioassay (3rd International Standard)	Biotherapeutics	Protein Hormones and Endocrine Products
11/176	(3rd International Standard) Low Molecular Weight Heparin	Vaccines	Influenza
11/184	High Molecular Weight Urokinase(2nd International Standard)	Vaccines	Influenza
11/206	Influenza anti-A/Perth/16/2009 HA Serum	Vaccines	Influenza
11/206	Influenza anti-A/Perth/16/2009 HA Serum	Vaccines	Influenza
11/210	Anti-human CD4 FITC conjugated 0.5ml	Biotherapeutics	Protein Hormones and Endocrine Products
11/212	Biosynthetic Human Insulin (2nd WHO international Standard)	Biotherapeutics	Haemostasis
11/214	Blood Group Genotyping Reference Reagents Panel (WHO Reference Reagent)	Vaccines	Influenza
11/216	Chagas Antibody Reference Panel ( 1st International Standard)	Vaccines	Influenza
11/222	Influenza Virus Infectious NIB-79	Vaccines	Influenza
11/232	Influenza Virus Infectious B/Texas/6/2011	Vaccines	Influenza
11/234	Immunoglobulin E(IgE) human serum (3rd International Standard)	Vaccines	Influenza
11/242	Viral Multiplex Reference	Diagnostics	Protein Hormones and Endocrine Products
11/244	Influenza Virus Infectious NYMC BX-49	Diagnostics	Allergen
12/100	Influenza Virus Infectious NYMC X-217	Diagnostics	Allergen
12/104	International Standard for IPV 12/104 (3rd International Standard)	Diagnostics	Allergen
12/106	Influenza Antigen B/Hubei-Wujiagang/158/2009 (NYMCBX-39)	Vaccines	Influenza
12/110	Influenza Antigen B/Wisconsin/1/2010 (cell derived)	Vaccines	Influenza
12/112	Influenza Antigen A/Victoria/210/2009 (H3N2) (NYMCX-187)	Biotherapeutics	Protein Hormones and Endocrine Products
12/114	Influenza Antigen A/Victoria/361/2011 (H3N2) (IVR-165)	Biotherapeutics	Protein Hormones and Endocrine Products
12/116	Influenza anti-A/Victoria/361/2011-like HA serum	Diagnostics	Immunoglobulins and Immune Sera
12/118	Influenza anti-B/Wisconsin/1/2010-like HA serum	Biotherapeutics	Protein Hormones and Endocrine Products
12/122	Influenza virus infectious A/turkey/Italy/3889/1999 (H7N1)	Diagnostics	Allergen
12/154	Tumour Necrosis Factor alpha (human rDNA derived)(3rd International Standard)	Diagnostics	Allergen
12/188	Pegylated Granulocyte Colony Stimulating Factor (Human, rDNA derived) (1st International Standard)	Diagnostics	Allergen
12/198	Influenza virus infectious B/Wisconsin/1/2010 34490 E5	Biotherapeutics	Protein Hormones and Endocrine Products
12/202	Influenza virus infectious NYMC BX-39	Diagnostics	Allergen
12/204	Influenza Virus Infectious IVR-165	Diagnostics	Allergen
12/208	Parvovirus B19 (3rd International Standard)	Diagnostics	Immunoglobulins and Immune Sera
12/224	HIV-1 NAT subtypes (Main)(2nd International Reference Panel Preparation)	Vaccines	Influenza
12/226	HBsAg (HBV genotype B4, HBsAg subtypes ayw1/adw2)(3rd International Standard)	Vaccines	Influenza
12/244	Vi polysaccharide of C freundii WHO 1st International Standard	Biotherapeutics	Protein Hormones and Endocrine Products
12/250	Influenza anti A/Mallard/England 727/2006 (H2) HA Serum	Diagnostics	Immunoglobulins and Immune Sera
12/252	ADAMTS 13 Plasma (1st International Standard)	Biotherapeutics	Protein Hormones and Endocrine Products
12/278	2nd Pneumococcal QC Serum Panel	Vaccines	Influenza
12/282	Diphtheria Toxin 1Lf/ml	Diagnostics	Immunoglobulins and Immune Sera
12/284	Anti-meningococcal serogroup Y monoclonal antibody	Diagnostics	Allergen
12/290	Influenza Virus Infectious B/Brisbane/36/2012	Diagnostics	Protein Hormones and Endocrine Products
12/294	Influenza Virus Infectious NYMC BX-51C	Biotherapeutics	Haemostasis
12/300	Negative Control IVIG (for use with IVIG and Anti-D)	Diagnostics	Protein Hormones and Endocrine Products
12/306	Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP)(2nd International Standard)	Diagnostics	Protein Hormones and Endocrine Products
13/100	Activated Blood Coagulation Factor XI (FXIa), Human (1st International Standard)	Diagnostics	Protein Hormones and Endocrine Products
13/106	Influenza Antigen B/Massachusetts/02/2012	Diagnostics	Protein Hormones and Endocrine Products
13/108	Anti-Meningococcal serogroup B monoclonal antibody	Diagnostics	Allergen
13/112	Influenza Antigen A/Texas/50/2012 (NYMC X-223)	Biotherapeutics	Haemostasis
13/116	Influenza Antigen A/Texas/50/2012 (NYMC X-223A)	Diagnostics	Miscellaneous
13/122	Erythropoietin Antibody Reference Panel Negative Control Antibody (1st WHO Reference Panel)	Diagnostics	Protein Hormones and Endocrine Products
13/126	Influenza anti-B/Brisbane/60/2008-like HA serum	Vaccines	Enteric disease
13/128	Influenza Virus Infectious NIBRG-269	Vaccines	Enteric disease
13/132	Antibodies, Human, to Toxoplasma gondii (4th International Standard).	Diagnostics	Protein Hormones and Endocrine Products
13/134	Influenza Antigen B/Massachusetts/02/2012 (Egg derived)	Diagnostics	Blood Transfusion and Transplantation
13/146	C-Peptide, Human (1st International Standard).	Vaccines	Malaria
13/148	IVIG + anti-D for use with negative control IVIG	Vaccines	Malaria
13/152	Influenza Antigen B/Massachusetts/02/2012 (Cell Derived)	Vaccines	Malaria
13/162	Influenza Antigen A/Texas/50/2012 (NYMC X-223A) (Cell derived)	Vaccines	Malaria
13/164	Influenza Antigen A/California/7/2009 (H1N1pdm)(NYMC X-179A)	Vaccines	Malaria
13/166	Influenza anti-A/Anhui/1/2013 (N9) NA Serum	Vaccines	Malaria
13/168	Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques	Vaccines	Malaria
13/172	Lupus Anticoagulant (1st International Reference Panel)	Biotherapeutics	Protein Hormones and Endocrine Products
13/176	Influenza Virus Infectious NIBRG-88	Vaccines	Pertussis
13/178	Influenza Anti-A/Texas/50/2012-like HA serum	Biotherapeutics	Protein Hormones and Endocrine Products
13/182	Influenza Anti-B/Massachusetts/02/2012-like HA Serum	Diagnostics	Immunoglobulins and Immune Sera
13/200	Influenza Virus Infectious NIB-74	Biotherapeutics	Protein Hormones and Endocrine Products
13/202	Influenza Virus infectious NIB-74xp	Diagnostics	Immunoglobulins and Immune Sera
13/204	TNF Rec II- FC Fusion protein (1st International Standard)	Diagnostics	Immunoglobulins and Immune Sera
13/206	Plasmin (4th International Standard)	Diagnostics	Immunoglobulins and Immune Sera
13/212	Diphtheria Toxoid for use in Flocculation Test (3rd International Standard)	Diagnostics	Immunoglobulins and Immune Sera
13/214	HIV-1 Circulating Recombinant Forms RNA (1st International Reference Panel)	Diagnostics	Immunoglobulins and Immune Sera
13/216	Anti-meningococcal factor H binding protein variant 1 (JAR5) monoclonal	Vaccines	Diphtheria
13/218	Polio Anti Sabin type 1 (inactivated) Serum	Biotherapeutics	Protein Hormones and Endocrine Products
13/218	Polio Anti Sabin type 1 (inactivated) Serum	Diagnostics	Protein Hormones and Endocrine Products
13/220	Polio Anti Sabin type 2 (inactivated) serum	Biotherapeutics	Protein Hormones and Endocrine Products
13/220	Polio Anti Sabin type 2 (inactivated) serum	Diagnostics	Protein Hormones and Endocrine Products
13/222	Polio Anti Sabin type 3 (inactivated) serum	Diagnostics	Quality Control Reagent (D)
13/222	Polio Anti Sabin type 3 (inactivated) serum	Vaccines	Clostridium
13/224	Influenza virus Infectious NIB-85. 36210 E5	Vaccines	Clostridium
13/228	Influenza Virus Infectious. A/Almaty/2958/2013. 35790 E4	Biotherapeutics	Immunoglobulins and Immune Sera
13/234	Influenza antigen B/Brisbane/60/08	Vaccines	Clostridium
13/238	Anti-EV71 serum LOW (WHO Reference Reagent)	Biotherapeutics	Protein Hormones and Endocrine Products
13/240	Tetanus Immunoglobulin, Human (2nd WHO International Standard)	Vaccines	Tetanus
13/242	FEIBA Concentrate 2nd NIBSC Working Reference Standard	Vaccines	Botulinum
13/246	Meningococcal serogroup A polysaccharide (1st WHO International Standard).	Vaccines	Botulinum
13/248	Influenza virus infectious NIBRG-267 (H7N9)	Biotherapeutics	Protein Hormones and Endocrine Products
13/250	Influenza Virus Infectious NIBRG-268 (H7N9)	Vaccines	Clostridium
13/252	Influenza virus infectious NYMC X-223A	Vaccines	Pertussis
13/256	Influenza virus infectious. NYMC x-233	Vaccines	Clostridium
13/258	Influenza virus infectious NYMC X-233A	Vaccines	Clostridium
13/262	Meningococcal serogroup A polysaccharide	Diagnostics	Livestock diseases
13/264	Influenza Virus Infectious NYMC X-223	Vaccines	Influenza
14/100	Human Papillomavirus (HPV) 11 DNA (1st International Standard)	Vaccines	Influenza
14/104	Human Papillomavirus (HPV) Type 45 DNA (1st International Standard)	Vaccines	Influenza
14/106	Influenza virus infectious. NYMC BX-51B	Vaccines	Pertussis
14/114	JC Virus (JCV) DNA (1st International Standard)	Vaccines	Meningococcal Reagents
14/116	Influenza Virus Infectious NYMC X-179A	Vaccines	Influenza
14/118	Influenza virus infectious B/Massachusetts/2/2012	Vaccines	Influenza
14/140	1st International Standard for Anti EV71 Serum Human	Vaccines	Influenza
14/144	Influenza anti-N2 Neuraminidase serum (A/Victoria/361/2011)	Vaccines	Influenza
14/146	Influenza Antigen B/Brisbane/60/2008 (NYMCBX-35)(Cell Derived)	Vaccines	Influenza
14/148	Human Blood Factor IX Concentrate (5th International Standard).	Vaccines	Influenza
14/156	Meningococcal group X polysaccharide (1st WHO International Standard)	Vaccines	Influenza
14/160	High titre anti-A in IVIG working reference reagent	Vaccines	Influenza
14/174	Botulinum Type A Antitoxin, Equine	Vaccines	Influenza
14/198	HBV,HCV,HIV Multiplex	Vaccines	Influenza
14/198	HBV,HCV,HIV Multiplex	Vaccines	Influenza
14/200	Influenza Antigen A/Puerto Rico/8/34 (HINI)	Vaccines	Meningococcal Reagents
14/206	Influenza virus infectious NYMC X-247	Vaccines	Influenza
14/210	Biological activities of Rituximab WHO 1st International Standard	Diagnostics	Quality Control Reagent (D)
14/212	BK Virus (BKV)(1st International Standard)	Diagnostics	Quality Control Reagent (D)
14/224	Influenza virus infectious. A/Switzerland/9715293/2013	Diagnostics	Quality Control Reagent (D)
14/226	Influenza Virus Infectious A/South Australia/55/2014	Vaccines	Influenza
14/228	Influenza Virus Infectious A/Stockholm/6/2014	Vaccines	Influenza
14/230	Influenza Virus Infectious. A/Norway/466/2014	Vaccines	Influenza
14/232	Influenza Virus Infectious IVR-175	Vaccines	Influenza
14/238	Recombinant Tissue factor	Vaccines	Pneumococcal vaccines
14/254	Influenza Antigen A/Switzerland/9715293/2013 (NIB88)	Vaccines	Pneumococcal vaccines
14/256	Human Papillomavirus (HPV) Type 6 DNA (1st International Standard)	Vaccines	Pneumococcal vaccines
14/258	Human Papillomavirus (HPV) Type 31 DNA (1st International Standard)	Vaccines	Pneumococcal vaccines
14/260	Human Papillomavirus (HPV) Type 33 DNA (1st International Standard)	Vaccines	Pneumococcal vaccines
14/262	Human Papillomavirus (HPV) Type 52 DNA (1st International Standard)	Vaccines	Pneumococcal vaccines
14/264	Human Papillomavirus (HPV) Type 58 DNA (1st International Standard)	Vaccines	Pneumococcal vaccines
14/274	Influenza Antigen B/Brisbane/9/2014 (Egg Derived)	Vaccines	Pneumococcal vaccines
14/300	High titre anti-A and anti-B in serum (WHO Reference Reagent).	Vaccines	Pneumococcal vaccines
14/306	Influenza Virus Infectious NYMC X-243 40180 E13	Vaccines	Pneumococcal vaccines
14/308	Influenza Virus Infectious IVR-178 40200 E7	Vaccines	Pneumococcal vaccines
14/314	Influenza Virus Infectious NIB-88	Vaccines	Pneumococcal vaccines
14/316	Factor IX activated (FIXa) 2nd WHO International Standard	Vaccines	Pneumococcal vaccines
14/318	Influenza Anti NIBRG-301 (H5) HA Serum (Sheep SH624 and SH625)	Vaccines	Pneumococcal vaccines
14/322	Influenza Virus Infectious NIB-91	Vaccines	Pneumococcal vaccines
15/100	Influenza Antigen B/Utah/9/2014 (Cell Derived)	Vaccines	Pneumococcal vaccines
15/102	Activated Blood Coagulation Factor X (FXa), Human	Vaccines	Pneumococcal vaccines
15/104	Influenza Antigen A/South Australia/55/2014 Cell derived	Vaccines	Influenza
15/106	Ancrod	Biotherapeutics	Immunogenicity
15/126	Bordetella pertussis toxin (20µg). (2nd International Standard)	Vaccines	Emerging Viruses (V)
15/130	Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT)	Vaccines	Influenza
15/134	Influenza Anti-A Switzerland/9715293/2013-Like HA serum	Vaccines	Pneumococcal vaccines
15/134	Influenza Anti-A Switzerland/9715293/2013-Like HA serum	Vaccines	Pneumococcal vaccines
15/136	EBOV RNA NP-VP35-GP in-run control	Vaccines	Pneumococcal vaccines
15/138	EBOV RNA VP40-L in-run control	Vaccines	Pneumococcal vaccines
15/140	Batroxobin	Vaccines	Pneumococcal vaccines
15/148	Influenza Virus Infectious NIB-92	Vaccines	Pneumococcal vaccines
15/154	Influenza Virus Infectious NIB-93	Vaccines	Pneumococcal vaccines
15/158	Influenza Virus Infectious NYMC X-263	Vaccines	Pneumococcal vaccines
15/160	Influenza Virus Infectious NIBRG-306	Vaccines	Pneumococcal vaccines
15/174	Lupus (oligo-specific) anti-dsDNA antibodies WHO Reference Reagent	Vaccines	Pneumococcal vaccines
15/180	Blood Coagulation Factor XI, 2016 Plasma Human (2nd International Standard). Blood Coagulation Factor XII, 2017 Plasma, Human (1st International Standard)	Vaccines	Pneumococcal vaccines
15/182	7th British Working Standard for Blood Coagulation Factors II, IX, X Concentrate	Vaccines	Pneumococcal vaccines
15/184	Influenza Virus Infectious NYMC X-263B	Vaccines	Pneumococcal vaccines
15/188	Influenza Virus Infectious NYMC X-263A	Vaccines	Pneumococcal vaccines
15/194	Influenza Virus Infectious NYMC X-257A	Vaccines	Pneumococcal vaccines
15/196	Influenza Virus Infectious NYMC X-261	Vaccines	Influenza
15/212	Influenza Virus Infectious NYMC BX-53C	Vaccines	Influenza
15/220	Anti-EBOV plasma, human (WHO Reference Reagent)	Vaccines	Influenza
15/222	EBOV RNA NP-VP35-GP (WHO Reference Reagent)	Vaccines	Influenza
15/224	EBOV RNA VP40-L (WHO Reference Reagent)	Vaccines	Influenza
15/234	Influenza Virus Infectious B/Texas/2/2013 41340 E7	Vaccines	Influenza
15/238	Influenza Antigen A/New Caledonia/71/2014 (NYMCX-257A)(Egg derived antigen)	Vaccines	Influenza
15/240	Erythropoietin Antibody Reference Panel A (1st WHO Reference Panel)	Vaccines	Influenza
15/242	Erythropoietin Antibody Reference Panel B (1st WHO Reference Panel)	Vaccines	Influenza
15/248	Influenza Anti A/Anhui/1/2013 (H7) HA Serum (Sheep SH644 & SH645)	Vaccines	Influenza
15/250	Influenza Virus Infectious NYMC BX-31	Vaccines	Influenza
15/262	1st International Standard for Ebola virus (EBOV) antibodies Sierra Leone Convalescent Plasma Pool	Vaccines	Influenza
15/266	HHV-6 Virus 1st WHO International Standard	Vaccines	Influenza
15/270	1st WHO International Reference Reagent CD4 T-cells (human)	Vaccines	Influenza
15/272	ICS Positive Control-Lymphocytes	Vaccines	Influenza
15/276	Hepatitis A Virus VL For Nucleic Acid Amplification Techniques (3rd International Standard)	Vaccines	Influenza
15/294	Influenza virus infectious NYMC BX-59B	Vaccines	Influenza
15/296	Sabin monovalent Polio vaccine type 2 (1st International Standard)	Vaccines	Influenza
15/298	Influenza Virus Infectious B/Brisbane/46/2015	Vaccines	Influenza
15/300	Influenza Virus Infectious NYMC BX-35 41950 E11	Vaccines	Influenza
15/304	Parathyroid hormone 1-34, recombinant, human, 2nd WHO International Standard	Vaccines	Influenza
16/106	Influenza antigen A/California/7/09 (H1N1) (NYMC-X181)	Vaccines	Meningococcal Reagents
16/108	Influenza Virus Infectious A/PR/8/34	Vaccines	Influenza
16/110	Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT)	Vaccines	Influenza
16/114	Influenza anti - A/California/7/09 HA serum	Vaccines	Influenza
16/118	Influenza Antigen B/Brisbane/60/2008 (NYMC BX-35) (Egg Derived)	Vaccines	Influenza
16/120	WHO 1st International Reference Panel for Genomic JAK2 V617F	Vaccines	Influenza
16/126	Native Vi polysaccharide (S. Typhi) (1st International Standard)	Vaccines	Influenza
16/138	Anti-Typhoid capsular Vi polysaccharide Ig (Human) 1st WHO International Standard	Vaccines	Influenza
16/152	Meningococcal serogroup W polysaccharide	Vaccines	Influenza
16/164	Sabin bivalnet Polio vaccines types 1 and 3 (1st International Standard)	Vaccines	Influenza
16/170	Infliximab (1st International Standard)	Vaccines	Influenza
16/182	Influenza Anti-A/Hong Kong/4801/2014-like HA Serum	Vaccines	Influenza
16/190	Mullerian Inhibiting Substance/Anti-Mullerian Hormone, human, recombinant (WHO reference Reagent)	Diagnostics	Blood Borne Pathogens
16/192	Influenza Anti - B/Brisbane/60/2008-HA serum	Vaccines	Influenza
16/194	HIV-1 RNA (4th International Standard)	Diagnostics	Emerging Viruses (D)
16/196	Sabin monovalent Polio vaccine type 1(1st International Standard)	Vaccines	Emerging Viruses (V)
16/200	Influenza Virus Infectious NIB-58	Vaccines	Emerging Viruses (V)
16/202	OPV reference mOPV 3	Vaccines	Influenza
16/204	7th WHO International Standard for Rabies Vaccine	Diagnostics	Blood Borne Pathogens
16/206	Meningococcal serogroup Y Polysaccharide	Diagnostics	Quality Control Reagent (D)
16/208	Influenza Virus Infectious NIB-97 42090 E7	Diagnostics	Quality Control Reagent (D)
16/210	HIV-1 P24 Antigen (1st international reference panel)	Vaccines	Influenza
16/236	HIV-2 p26 Antigen (VLP)-HIV-2 A7312 (1st WHO Reference Reagent)	Vaccines	Influenza
16/238	Influenza Antigen A/Anhui/1/2013 (NIBRG-268) (H7N9)	Vaccines	Influenza
16/242	Influenza Virus Infectious NIB-98 42110 E7	Vaccines	Influenza
16/250	1st International Reference Panel for genomic KRAS codons 12 and 13 mutations	Vaccines	Influenza
16/268	Influenza Virus Infectious X-273	Vaccines	Influenza
16/270	Influenza Virus Infectious IVR-180 42400 E3/D7/E1	Vaccines	Influenza
16/274	Influenza Virus Infectious X-275A 42010 E13	Biotherapeutics	Blood Transfusion and Transplantation
16/278	Anti-D Immunglobulin control preparation	Diagnostics	Emerging Viruses (D)
16/282	Influenza Virus Infectious X-285 42430 ExE1	Vaccines	Influenza
16/284	Antiserum to Respiratory Syncytial Virus WHO 1st International Standard	Vaccines	Influenza
16/286	Influenza Antigen A/Hong Kong/4801/2014 (NYMC X-263B)	Vaccines	Influenza
16/288	Influenza Virus Infectious X-283A 42420 ExE1	Vaccines	Influenza
16/290	Influenza Virus Infectious X-285A 42440 ExE1	Vaccines	Influenza
16/292	Influenza Antigen A/Singapore/GP1908/2015 (IVR-180)	Vaccines	Emerging Viruses (V)
16/296	Human Immunodeficiency Virus type 2 RNA (HIV-2) for Nucleic Acid Amplification Techniques (2nd International Standard)	Vaccines	Emerging Viruses (V)
16/302	Tetanus Toxoid for use in Flocculation Test (3rd International Standard)	Vaccines	Influenza
16/320	Zika Antibody Working reagent	Vaccines	Emerging Viruses (V)
16/324	Human Adenovirus DNA for nucleic acid amplification techniques (1st WHO international Standard).	Vaccines	Influenza
16/332	Anti-D Immunoglobulin (Replacement IS)	Vaccines	Influenza
16/344	WHO Anti-EBOV Convalescent Plasma (International Reference Panel)	Vaccines	Influenza
16/352	Anti-Asian Lineage Zika Virus Antibody (human) (1st international standard)	Vaccines	Influenza
16/358	Streptokinase (4th WHO International Standard)	Vaccines	Influenza
16/360	Influenza Virus Infectious NIB-96 41920 E7	Vaccines	Influenza
16/362	Influenza Virus Infectious NYMC X-291 42530 E8	Vaccines	Influenza
16/364	3rd International Standard for Prekallikrein Activator	Biotherapeutics	Cytokines and Growth Factors
16/366	Influenza Virus Infectious NYMC X-291A 42540 E8	Vaccines	Influenza
16/368	HSV-1	Vaccines	Influenza
16/374	Blood Coagulation Factor V, Plasma, Human. (WHO 2nd International Standard)	Vaccines	Pneumococcal vaccines
16/376	Plasmodium falciparum antigens (1st International Standard)	Vaccines	Pneumococcal vaccines
16/376	Plasmodium falciparum antigens (1st International Standard)	Vaccines	Pneumococcal vaccines
1-7	Fimbrae monoclonal antibody, clone 1-7	Vaccines	Pneumococcal vaccines
17/100	Prostate Specific Antigen (human)(total: PSA-ACT + free PSA)	Vaccines	Pneumococcal vaccines
17/102	Prostate Specific Antigen (human) (Free), (2nd WHO International Standard)	Vaccines	Pneumococcal vaccines
17/106	Influenza Anti-A/Michigan/45/2015-like HA Serum	Vaccines	Pneumococcal vaccines
17/106	Influenza Anti-A/Michigan/45/2015-like HA Serum	Vaccines	Pneumococcal vaccines
17/122	HSV-2	Vaccines	Pneumococcal vaccines
17/124	Influenza Virus Infectious NYMC BX-63 42790 E10/E1	Vaccines	Pneumococcal vaccines
17/126	Influenza Virus Infectious NYMC BX-63A 42780 E10/E1	Vaccines	Pneumococcal vaccines
17/132	Influenza Anti NIBRG-306 (H5) HA Serum (sheep SH672 and SH637)	Vaccines	Pneumococcal vaccines
17/136	Influenza Virus Infectious NIBRG-375 (H7N9)	Vaccines	Pneumococcal vaccines
17/142	Influenza Antigen A/Duck Vietnam/NCVD-1584/2012 (NIBRG-301) (H5N1)	Vaccines	Pneumococcal vaccines
17/154	Influenza Antigen A/Michigan/45/2015 (NYMC X-275)	Vaccines	Pneumococcal vaccines
17/154	Influenza Antigen A/Michigan/45/2015 (NYMC X-275)	Diagnostics	Immunoglobulins and Immune Sera
17/156	Influenza Virus Infectious CNIC-1701 42910 E9	Vaccines	Influenza
17/160	Sabin Inactivated Polio Vaccine (sIPV) (WHO 1st international Standard)	Vaccines	Influenza
17/162	Influenza Virus Infectious NYMC X-299 42920 E10	Vaccines	Influenza
17/164	Influenza Virus Infectious B/Maryland/15/2016 42800 E5	Vaccines	Influenza
17/182	Influenza Antigen A/Michigan/45/2015 (NYMC X-275)	Vaccines	Influenza
17/184	Influenza Virus Infectious NIB-103 42610 E7	Vaccines	Influenza
17/190	Influenza Virus Infectious NYMC X-297 42940 E11	Vaccines	Influenza
17/194	Influenza Virus Infectious NIB-104	Vaccines	Influenza
17/204	1st International Standard for Darbepoetin	Vaccines	Influenza
17/206	14th British Standard for Coagulation Factor VIII Concentrate, Human.	Vaccines	Influenza
17/210	Influenza Virus Infectious IVR-186 43310 E8	Vaccines	Influenza
17/212	Anti-human leukocyte antigen antibodies (negative serum)	Vaccines	Anti-Toxins
17/232	Tumor Necrosis Factor alpha (human rDNA derived)	Vaccines	Clostridium
17/236	Adalimumab (1st WHO International Standard)	Vaccines	Tetanus
17/238	Anti-human leukocyte antigen antibodies (strong positive plasma)	Vaccines	Influenza
17/240	5% Immunoglobulin (Negative Control)	Vaccines	Influenza
17/246	Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (NIB-104)	Vaccines	Influenza
17/252	Influenza Virus Infectious NYMC BX-69 43220 E13	Vaccines	Influenza
17/256	Influenza Virus Infectious NYMC BX-69A	Vaccines	Influenza
17/256	Influenza Virus Infectious NYMC BX-69A	Vaccines	Influenza
17/258	Influenza Virus Infectious B/Alabama/2/2017	Vaccines	Influenza
17/264	Influenza Virus Infectious A/Michigan/45/2015 43470 E5	Vaccines	Influenza
18/100	Influenza Antigen B/Maryland/15/2016	Vaccines	Influenza
18/104	Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A)	Vaccines	Influenza
18/104	Influenza Antigen B/Maryland/15/2016 (NYMC BX-69A)	Vaccines	Influenza
18/108	Influenza anti-A/Singapore/INFIMH-16-0019/2016- like HA serum	Vaccines	Influenza
18/110	Influenza Antigen A/Singapore/INFIMH-16-0019/2016 (IVR-186)	Vaccines	Influenza
18/112	Influenza anti-A/Guangdong-17SF003/2016 (H7) (NIBRG-375) HA Serum	Vaccines	Influenza
18/116	WHO International Standard Enterovirus 71 (EV71) Inactivated vaccine (Geno Group C4)	Vaccines	Influenza
18/118	1st International Standard for HCT 15 Cancer Genome	Vaccines	Influenza
18/120	WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group C4)	Vaccines	Influenza
18/130	1st International Standard for MOLT-4 Cancer Genome	Vaccines	Influenza
18/132D	WHO Reference Reagent Lentiviral Vector Copy number by digital PCR 6.75 log 10 LV copies/ampoule	Vaccines	Meningococcal Reagents
18/132Q	WHO Reference Reagent Lentiviral Vector Copy number by quantitative PCR 6.89 log 10 LV copies/ampoule	Biotherapeutics	Monoclonal Antibodies
18/134	Influenza Virus Infectious NIBRG-301 (H5N1)	Vaccines	Influenza
18/136	Influenza Virus Infectious NIBRG-14 (H5N1)	Vaccines	Influenza
18/136	Influenza Virus Infectious NIBRG-14 (H5N1)	Vaccines	Influenza
18/138	Influenza Virus Infectious NYMC X-307A	Vaccines	Influenza
18/140	Influenza Virus Infectious NYMC X-307	Vaccines	Influenza
18/144	WHO 1st Reference Reagent for Lentiviral Vector Integration Site Analysis	Vaccines	Influenza
18/146	Pertussis antiserum (human) panel	Vaccines	Influenza
18/154	Bordetella pertussis, pertactin, PRN	Vaccines	Influenza
18/156	WHO Reference Reagent Enterovirus 71 (EV71) Inactivated Vaccine (Geno Group B4)	Vaccines	Influenza
18/160	Influenza Virus Infectious NYMC X-311	Vaccines	Influenza
18/164	1st International Standard for ATDB102 Genome	Vaccines	Influenza
18/166	Influenza Virus Infectious NIB-112 43990 E6	Vaccines	Influenza
18/168	Influenza Virus Infectious A/Switzerland/8060/2017	Vaccines	Influenza
18/170	Influenza anti-B/Colorado/06/2017-like HA serum	Vaccines	Influenza
18/174	Influenza Virus Infectious A/Brisbane/1/2018	Biotherapeutics	Haemostasis
18/180	2nd International Standard for Diphtheria Antitoxin Equine	Vaccines	Influenza
18/184	Hepatitis C virus RNA for nucleic acid amplification techniques (6th WHO International Standard)	Vaccines	Influenza
18/188	Influenza Antigen A / Switzerland / 8060 / 2017 (NIB-112)	Vaccines	Influenza
18/190	Influenza Antigen A / Brisbane/ 01/2018 (NYMC X-311)	Vaccines	Influenza
18/192	Influenza Anti-A/Switzerland/8060/2017-like (H3N2) HA Serum	Vaccines	Influenza
18/194	Influenza Virus Infectious NYMC X-275 (Influenza Reagent)	Vaccines	Influenza
18/196	Influenza Antigen A/Guangdong/17SF003/2016. NIBRG-375 (H7N9)	Vaccines	Influenza
18/204	1st International Standard Anti-citrullinated peptide antibodies (ACPA)	Vaccines	Influenza
18/206	West Nile Virus - International Standard	Diagnostics	Blood Borne Pathogens
18/208	WHO Reference Reagent for West Nile Virus lineage 2 RNA for NAT-based assays	Vaccines	Influenza
18/210	Bevacizumab (1st WHO International Standard)	Vaccines	Influenza
18/220	Anti-HPA 15b minimum potency reagent (WHO Reference Reagent)	Vaccines	Influenza
18/226	Influenza Virus Infectious IVR-190 44250 E12	Diagnostics	Emerging Viruses (D)
18/230	Influenza Virus Infectious B/Colorado/06/2017 43460 E7	Diagnostics	Emerging Viruses (D)
18/234	Influenza Virus Infectious NIB116-B 44230 E5	Vaccines	Influenza
18/236	Influenza Virus Infectious A/Brisbane/02/2018	Diagnostics	Quality Control Reagent (D)
18/238	Influenza Antigen A/Brisbane/02/2018 (IVR-190) (H1N1)	Diagnostics	Quality Control Reagent (D)
18/240	Influenza Virus Infectious NYMC X-327 44280 E17	Diagnostics	Quality Control Reagent (D)
18/242	Influenza Virus Infectious A/Kansas/14/2017 43880 E8	Diagnostics	Quality Control Reagent (D)
18/244	Human Chorionic Gonadotropin (hCG) (6th International Standard)	Diagnostics	Quality Control Reagent (D)
18/248	Von Willebrand Factor Concentrate (WHO 3rd International Standard)	Diagnostics	Quality Control Reagent (D)
19/102	Influenza anti-A/Brisbane/02/2018-like (H1N1) HA Serum (Sheep 698, 699, 700, 701)	Vaccines	Influenza
19/104	Influenza antigen A/Kansas/14/2017 (NYMC X-327) (H3N2)	Vaccines	Influenza
19/106	Influenza Virus Infectious IVR-195 44300 E9	Vaccines	Influenza
19/108	Trastuzumab (1st WHO international Standard)	Vaccines	Influenza
19/112	Influenza Virus Infectious NIB-110	Vaccines	Meningococcal Reagents
19/114	Anti-Human Neutrophil Antibody 3a WHO Reference Reagent	Vaccines	Influenza
19/116	1st WHO Plasmodium Vivax Antigen (LDH)	Diagnostics	Microbiome
19/118	Ferritin (Human, Recombinant)	Vaccines	Influenza
19/120	Influenza Virus Infectious X-327 A 44310 E18	Vaccines	Influenza
19/146	Influenza Virus Infectious CNIC-1903	Vaccines	Influenza
19/148	Influenza Virus Infectious CNIC-1902 44320 E10	Vaccines	Influenza
19/152	Influenza anti-A/Kansas/14/2017 - Like (H3N2) HA Serum	Biotherapeutics	Haemostasis
19/154	Influenza Antigen A/Kansas/ 12/2017 (IVR-195) (H3N2)	Vaccines	Influenza
19/156	Panel of recombinant antibody controls for Cytokine Release Assays	Vaccines	Influenza
19/160	Influenza Virus Infectious A/California/7/09 44430 E6	Diagnostics	Monoclonal Antibodies
19/164	VZV Nucleic acid amplification techniques (1st WHO International Standard)	Diagnostics	Monoclonal Antibodies
19/166	Insulin-like Growth Factor I, for Immunoassay (2nd WHO international Standard)	Diagnostics	Monoclonal Antibodies
19/172	Influenza Virus Infectious BVR-11	Diagnostics	Monoclonal Antibodies
19/174	Influenza Virus Infectious IVR-197 (H3N2) 44850 E14	Vaccines	Influenza
19/176	Influenza Virus Infectious B/Victoria/705/2018	Vaccines	Influenza
19/178	1st WHO International Standard for Anti-MERS-CoV Immunoglobulin G (Human)	Vaccines	Influenza
19/180	Non WHO Reference material Working reagent for Anti-MERS-CoV Antibody	Vaccines	Influenza
19/188	3rd International Standard Thrombin	Biotherapeutics	Protein Hormones and Endocrine Products
19/192	Influenza Virus Infectious IVR-202 (H3N2) 44880 E10	Vaccines	Influenza
19/194	Influenza Virus Infectious B/Brisbane/35/2018	Vaccines	Emerging Viruses (V)
19/198	1st WHO Reference Reagent for anti-malaria (Plasmodium Vivax) human plasma	Diagnostics	Miscellaneous
19/204	Influenza Antigen A/Newcastle/82/2018 (H3N2) (cell derived)	Diagnostics	Miscellaneous
19/206	Influenza Virus Infectious X-181 45030 E8	Diagnostics	Miscellaneous
19/208	Influenza Antigen B/Victoria/705/2018 (BVR-11) (B Victoria Lineage)	Diagnostics	Miscellaneous
19/210	Influenza Antigen B/Darwin/7/2019 (B Victoria Lineage) (Cell Derived)	Diagnostics	Miscellaneous
19/212	Influenza Antigen A/South Australia/34/2019 (IVR-197) (H3N2)	Diagnostics	Miscellaneous
19/216	Influenza Anti-A/South Australia/34/2019-Like (H3N2) HA Serum (Sheep 712, 713, 714, 715, 716)	Vaccines	Human Papillomavirus
19/224	Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV16, HPV18, HPV6, HPV11	Vaccines	Human Papillomavirus
19/226	Collection of WHO International Standards for Human Papillomavirus (HPV) DNA genotypes HPV31, HPV33, HPV45, HPV52, HPV58	Vaccines	Human Papillomavirus
19/228	Influenza Virus Infectious A/South Australia/34/2019	Diagnostics	Immunoglobulins and Immune Sera
19/230	Influenza Virus Infectious A/Christchurch/516/2019 H3N2 45010 E4	Diagnostics	Quality Control Reagent (D)
19/238	Influenza Antigen B/Washington/02/2019 (B victoria Lineage)	Vaccines	Influenza
19/240	British Working Standard for Anti-HCV	Diagnostics	Quality Control Reagent (D)
19/244	Third WHO International Standard for Anti-Rabies Immunoglobulin	Diagnostics	Tuberculosis (D)
19/246	1st International Standard for human vascular endothelial growth factor-165 (VEGF165)	Diagnostics	Emerging Viruses (D)
19/256	Influenza Virus Infectious BX-85C 45230 E13	Diagnostics	Emerging Viruses (D)
19/258	Influenza Virus Infectious CNIC-1906 44910 E3+3/E9/E1	Vaccines	Influenza
19/260	Anti-thyroid peroxidase antibodies (1st WHO International Standard)	Vaccines	Influenza
19/276	Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5	Biotherapeutics	Immunoglobulins and Immune Sera
19/276	Influenza Virus Infectious NIB-121 (H3N2) 45180 E7/E1/E5	Diagnostics	Quality Control Reagent (D)
19/290	First WHO International Standard for anti-human papillomavirus type 33 serum	Vaccines	Influenza
19/296	First WHO International Standard for anti-human papillomavirus type 52 serum	Vaccines	Influenza
19/298	First WHO International Standard for anti-human papillomavirus type 6 serum	Vaccines	Influenza
19/298	First WHO International Standard for anti-human papillomavirus type 6 serum	Diagnostics	Quality Control Reagent (D)
19/300	First WHO International Standard for anti-human papillomavirus type 58 serum	Diagnostics	Quality Control Reagent (D)
19/306	Influenza Antigen A/Victoria/2454/2019 (IVR-207) (H1N1)	Vaccines	Influenza
19/308	Influenza Antigen B/Singapore/INFTT-16-0610/2016 (B Yamagata lineage) (cell derived)	Vaccines	Influenza
19/312	Influenza Antigen A/Guangdong-Maonan/SWL1536/2019 (CNIC-1909) (H1N1)	Vaccines	Influenza
19/314	Influenza Anti-A/ Guangdong-Maonan/SWL 1536/2019-like (H1N1) HA Serum (Sheep 723, 724, 725, 726, 727, 728)	Vaccines	Influenza
19/316	Influenza anti-A/hongKong/2671/2019-like (H3N2) HA Serum (Sheep 729, 730, 731, 732, 733, 734)	Vaccines	Influenza
19/318	Influenza anti-B/Washington/02/2019-like (B Victoria lineage) HA Serum (Sheep 737, 738, 739, 740, 741, 742)	Vaccines	Influenza
19/320	Influenza anti-N2 Neuraminidase Serum (A/South Australia/34/2019) (Sheep 735, 736)	Vaccines	Influenza
19/322	Influenza anti-B/Phuket/3073/2013-like (B Yamagata Lineage) HA serum	Vaccines	Influenza
20/102	Influenza Virus Infectious IVR-207 (H1N1) 45370 E4/E6/E1	Vaccines	Human Papillomavirus
20/106	Influenza Virus Infectious A/Victoria/2454/2019 (H1N1) 45360 E4/E1	Vaccines	Human Papillomavirus
20/108	Influenza Antigen A/HongKong/2671/2019 (NIB-121)(H3N2)	Vaccines	Human Papillomavirus
20/110	SARS-CoV-2 (NAT)	Vaccines	Human Papillomavirus
20/112	IVIG + Anti-D (13/148)x2 Negative Control IVIG (12/300) x2	Vaccines	Human Papillomavirus
20/132	Influenza Antigen A/HongKong/2671/2019 (IVR-208) (H3N2)	Vaccines	Influenza
20/134	Influenza Virus Infectious BX-57 45430 E4/E10/E1	Vaccines	Influenza
20/138	Working Reagent for SARS-CoV-2 RNA	Diagnostics	Protein Hormones and Endocrine Products
20/146	First WHO International Standard for SARS-CoV-2 RNA	Vaccines	Influenza
20/152	First WHO International Standard for Mycobacterium tuberculosis (H37Rv) DNA for NAT-based assays	Vaccines	Influenza
20/162	NIBSC Anti-SARS-CoV-2 Antibody Diagnostic Calibrant	Biotherapeutics	Cytokines and Growth Factors
20/164	Influenza Virus Infectious BX-87C (B/VIC) 45460 E3/E10/E1	Vaccines	Rabies
20/170	NHS winter Multiplex Working Reagent for Nucleic acid amplification testing (NAT)	Diagnostics	Blood Borne Pathogens
20/172	1st International Standard for anti-EV68 Serum	Vaccines	Influenza
20/174	First WHO International Standard for anti-human papillomavirus type 11 serum	Vaccines	Influenza
20/176	First WHO International Standard for anti-human papillomavirus type 31 serum	Vaccines	Influenza
20/178	First WHO International Standard for anti-human papillomavirus type 45 serum	Diagnostics	Human Papillomavirus
20/180	Influenza A (H1N1) Panel	Diagnostics	Human Papillomavirus
20/182	Influenza A (H3N2) Panel	Vaccines	Influenza
20/184	Influenza B Panel	Vaccines	Influenza
20/186	RSV A Panel	Vaccines	Influenza
20/188	RSV B Panel	Vaccines	Influenza
20/190	SARS-CoV-2 Panel	Vaccines	Influenza
20/202	Anti-Lassa Virus Antibodies (1st International Standard)	Vaccines	Influenza
20/214	Influenza Virus Infectious IVR-216 (H1N1) 45630 E4/D6/E1	Vaccines	Parasitology
20/218	Follicle Stimulating Hormone (3rd International Standard)	Vaccines	Influenza
20/220	Influenza Virus Infectious IVR-217 (H1N1) 45640 E4/D6/E1	Vaccines	Influenza
20/234	Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum (Sheep 749, 750, 751, 752, 753, 754)	Biotherapeutics	Haemostasis
20/236	Influenza Virus Infectious X-349 (H1N1) E3/E9/E1 45720	Vaccines	Emerging Viruses (V)
20/238	Influenza Virus Infectious X-349A (H1N1) E3/E11/E1 45730	Vaccines	Emerging Viruses (V)
20/250	WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 1	Vaccines	Influenza
20/252	WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 2	Vaccines	Influenza
20/254	WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Type 3	Vaccines	Influenza
20/256	WHO Reference Reagent Human Monoclonal Antibody for Poliovirus Types 1, 2 and 3	Diagnostics	Protein Hormones and Endocrine Products
20/264	Influenza Virus Infectious X-341 + 1P (H3N2)	Diagnostics	Blood Transfusion and Transplantation
20/264	Influenza Virus Infectious X-341 + 1P (H3N2)	Vaccines	Influenza
20/292	2nd International Standard for Factor XIII Plasma, Human	Biotherapeutics	Immunotoxicology
20/294	Influenza Virus Infectious X-347 (H3N2)	Vaccines	Influenza
20/294	Influenza Virus Infectious X-347 (H3N2)	Vaccines	Influenza
20/296	Influenza Virus Infectious X-347A (H3N2)	Vaccines	Influenza
20/296	Influenza Virus Infectious X-347A (H3N2)	Vaccines	Influenza
20/302	WHO International Reference Reagent for GUT Microbiome analysis by NGS (Gut-Mix RR)	Vaccines	Influenza
20/310	Influenza Virus Infectious A/Cambodia/E0826360/2020 (H3N2)	Diagnostics	Haematinics and Haemoglobin
20/314	2nd WHO International Standard For Meningococcal Capsular Group C Polysaccharide	Diagnostics	Parasitology
20/318	Influenza Virus Infectious IVR-221 (H3N2)	Biotherapeutics	Blood Transfusion and Transplantation
20/318	Influenza Virus Infectious IVR-221 (H3N2)	Vaccines	Influenza
20/322	Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 (H3N2)	Biotherapeutics	Monoclonal Antibodies
20/322	Influenza Virus Infectious A/Singapore/INFIMH-16-0019/2016 (H3N2)	Vaccines	Influenza
21/100	Influenza Antigen A/Cambodia/e0826360/2020 (IVR-224) (H3N2)	Vaccines	Influenza
21/110	Working Reagent for Lassa virus RNA	Vaccines	Influenza
21/112	First WHO International Standard for Lassa virus RNA	Diagnostics	Quality Control Reagent (D)
21/116	Influenza Antigen A/Tasmania/503/2020 (IVR-221) (H3N2)	Diagnostics	Quality Control Reagent (D)
21/118	Influenza anti-A/Cambodia/e0826360/ 2020-Like (H3N2) HA Serum	Diagnostics	Quality Control Reagent (D)
21/120	Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum	Vaccines	Quality Control Reagent
21/120	Influenza Anti-A/Victoria/2570/2019-like (H1N1) HA Serum	Biotherapeutics	Haemostasis
21/122	Influenza Virus Infectious X-357A (H3N2)	Biotherapeutics	Protein Hormones and Endocrine Products
21/122	Influenza Virus Infectious X-357A (H3N2)	Vaccines	Influenza
21/124	Influenza Virus Infectious B/HongKong/574/2019 (B-Victoria lineage)	Vaccines	Influenza
21/124	Influenza Virus Infectious B/HongKong/574/2019 (B-Victoria lineage)	Vaccines	Influenza
21/130	Influenza Virus Infectious SAN-004A (H3N2)	Vaccines	Influenza
21/130	Influenza Virus Infectious SAN-004A (H3N2)	Vaccines	Influenza
21/132	Influenza Virus Infectious B/Phuket/3073/2013 (B-Yamagata lineage)	Vaccines	Influenza
21/136	Influenza Antigen B/Phuket/3073/2013 (B Yamagata lineage)	Vaccines	Influenza
21/142	9th International Standard Factor VIII Concentrate, Human	Diagnostics	Blood Transfusion and Transplantation
21/148	Influenza Virus Infectious X-359 (H3N2)	Biotherapeutics	Monoclonal Antibodies
21/148	Influenza Virus Infectious X-359 (H3N2)	Diagnostics	Blood Borne Pathogens
21/150	Influenza Virus Infectious X-359A (H3N2)	Diagnostics	Blood Borne Pathogens
21/150	Influenza Virus Infectious X-359A (H3N2)	Biotherapeutics	Immunoglobulins and Immune Sera
21/156	Influenza Virus Infectious BX-93A (B-Victoria Lineage)	Vaccines	Influenza
21/156	Influenza Virus Infectious BX-93A (B-Victoria Lineage)	Vaccines	Influenza
21/158	Influenza Virus Infectious BX-93B (B-Victoria Lineage)	Vaccines	Influenza
21/158	Influenza Virus Infectious BX-93B (B-Victoria Lineage)	Vaccines	Influenza
21/160	Influenza Virus Infectious X-353 (H3N2)	Vaccines	Influenza
21/160	Influenza Virus Infectious X-353 (H3N2)	Diagnostics	Blood Borne Pathogens
21/164	Influenza Virus Infectious X-355B (H3N2)	Vaccines	Diphtheria
21/164	Influenza Virus Infectious X-355B (H3N2)	Vaccines	Influenza
21/166	Influenza Virus Infectious X-355A-CL (H3N2)	Vaccines	Influenza
21/166	Influenza Virus Infectious X-355A-CL (H3N2)	Vaccines	Influenza
21/170	1st International Standard 2022 for the in vitro bioactivities of Cetuximab	Vaccines	Influenza
21/180	Meningococcal Capsular Group W polysaccharide	Diagnostics	Genomic Reference Material
21/186	Influenza Virus Infectious A/Tasmania/503/2020 (H3N2)	Vaccines	Influenza
21/186	Influenza Virus Infectious A/Tasmania/503/2020 (H3N2)	Vaccines	Entero Virus
21/190	Influenza Virus Infectious X-361A (H3N2)	Vaccines	Pertussis
21/190	Influenza Virus Infectious X-361A (H3N2)	Vaccines	Pertussis
21/192	Influenza Virus Infectious BX-97A (B-Victoria Lineage)	Biotherapeutics	Gene Therapy
21/192	Influenza Virus Infectious BX-97A (B-Victoria Lineage)	Vaccines	Influenza
21/194	Influenza Virus Infectious A/Hong Kong/2671/2019	Vaccines	Influenza
21/194	Influenza Virus Infectious A/Hong Kong/2671/2019	Vaccines	Influenza
21/196	Influenza Virus Infectious IVR-224 (H3N2)	Vaccines	Influenza
21/196	Influenza Virus Infectious IVR-224 (H3N2)	Vaccines	Influenza
21/204	Influenza Virus Infectious IVR-227 (H3N2)	Biotherapeutics	Gene Therapy
21/212	Influenza Virus Infectious A/Darwin/6/2021 (H3N2)	Biotherapeutics	Gene Therapy
21/214	Influenza Virus Infectious A/Darwin/9/2021 (H3N2)	Diagnostics	Genomic Reference Material
21/216	Influenza Virus Infectious BVR-25 (B-Victoria Lineage)	Vaccines	Entero Virus
21/216	Influenza Virus Infectious BVR-25 (B-Victoria Lineage)	Diagnostics	Genomic Reference Material
21/224	Influenza Virus Infectious B/Austria/1359之417/2021 (B/Victoria Lineage)	Vaccines	Entero Virus
21/226	Influenza Virus Infectious NIB-127 (H3N2)	Vaccines	Influenza
21/228	Influenza Virus Infectious NIB-126 (H3N2)	Vaccines	Influenza
21/230	1st WHO Reference Reagent Tetanus Antitoxin Equine for use in Flocculation Test	Vaccines	Influenza
21/230	1st WHO Reference Reagent Tetanus Antitoxin Equine for use in Flocculation Test	Vaccines	Influenza
21/230	1st WHO Reference Reagent Tetanus Antitoxin Equine for use in Flocculation Test	Vaccines	Influenza
21/238	Influenza Virus Infectious A/Guangdong-Maonan/SWL/1536/2019 (H1N1)	Vaccines	Influenza
21/238	Influenza Virus Infectious A/Guangdong-Maonan/SWL/1536/2019 (H1N1)	Diagnostics	Quality Control Reagent (D)
21/240	Influenza Virus Infectious CNIC-1909 (H1N1)	Diagnostics	Quality Control Reagent (D)
21/240	Influenza Virus Infectious CNIC-1909 (H1N1)	Diagnostics	Quality Control Reagent (D)
21/242	Influenza Virus Infectious B/Singapore/WUH4618/2021 (B-Victoria Lineage)	Diagnostics	Quality Control Reagent (D)
21/242	Influenza Virus Infectious B/Singapore/WUH4618/2021 (B-Victoria Lineage)	Diagnostics	Quality Control Reagent (D)
21/244	Influenza Virus Infectious B/Michigan/1/2021 (B/Victoria Lineage)	Vaccines	Influenza
21/246	Influenza Virus Infectious IVR-228 (H3N2)	Vaccines	Influenza
21/248	Influenza Virus Infectious BVR-27 (B-Victoria Lineage) 46580	Catalogue	Influenza
21/248	Influenza Virus Infectious BVR-27 (B-Victoria Lineage) 46580	Vaccines	Influenza
21/252	Influenza Virus Infectious IVR-215 (H1N1)	Vaccines	Influenza
21/266	1st International Standard 2022 Anti-β2GPI IgG 200 IU/Vial	Vaccines	Influenza
21/268	Anti-pneumococcal serotype 1 monoclonal antibody (clone13-110A	Biotherapeutics	Immunoglobulins and Immune Sera
21/268	Anti-pneumococcal serotype 1 monoclonal antibody (clone13-110A	Biotherapeutics	Blood Transfusion and Transplantation
21/270	Anti-pneumococcal serotype 3 monoclonal antibody (clone 15-103FC11 IH5)	Biotherapeutics	Monoclonal Antibodies
21/272	Anti-pneumococcal serotype 5 monoclonal antibody (clone 1366LC1 IE11)	Biotherapeutics	Cytokines and Growth Factors
21/274	Anti-pneumococcal serotype 6A / 6C monoclonal antibody (clone 14-107 JG10 IA1/IB1 IIG10)	Biotherapeutics	Blood Transfusion and Transplantation
21/276	Anti-pneumococcal serotype 7F monoclonal antibody (clone 15-102HG6 ID8)	Vaccines	Influenza
21/278	Anti-pneumococcal serotype 8 monoclonal antibody (clone 7D3)	Biotherapeutics	Haemostasis
21/280	Anti-pneumococcal serotype 9N monoclonal antibody (clone 18-125BG4 ID4)	Biotherapeutics	Protein Hormones and Endocrine Products
21/282	Anti-pneumococcal serotype 9V monoclonal antibody (clone 15-112EG9 IE2)	Vaccines	Influenza
21/284	Anti-pneumococcal serotype 10A monoclonal antibody (clone 17-117IA3 IIB6)	Vaccines	Influenza
21/286	Anti-pneumococcal serotype 12F monoclonal antibody (clone 1C1)	Vaccines	Influenza
21/288	Anti-pneumococcal serotype 14 monoclonal antibody (clone 13-111A)	Vaccines	Influenza
21/290	Anti-pneumococcal serotype 18C monoclonal antibody (clone 15-104AG5 IIH4)	Vaccines	Influenza
21/292	Anti-pneumococcal serotype 19A monoclonal antibody (clone 14-105IH8 IE12)	Vaccines	Influenza
21/294	Anti-pneumococcal serotype 22F monoclonal antibody (clone 17-122 CG1 IC3)	Vaccines	Polio
21/298	Influenza Virus Infectious A/Michigan/173/2020 (H3N2)	Vaccines	Influenza
21/306	Influenza Virus Infectious SAN-010 (H3N2)	Vaccines	Influenza
21/308	2nd International Standard for Interleukin-6	Vaccines	Influenza
21/314	Influenza Antigen A/Darwin/6/2021 (IVR-227) (H3N2)	Vaccines	Influenza
21/316	Influenza Antigen B/Austria/1359之417/2021 (BVR-26) (B Victoria Lineage)	Vaccines	Influenza
21/318	Influenza Antigen A/Darwin/9/2021 (IVR-228) (H3N2)	Vaccines	Influenza
21/320	Influenza Antigen A/Darwin/9/2021 (SAN-010) (H3N2)	Vaccines	Influenza
21/322	Influenza Anti-B Neuraminidase Serum (B/Phuket/3073/2013)	Vaccines	Influenza
21/326	Influenza Anti-B/Austria/1359之417/2021 Like (B Victoria Lineage) HA Serum	Diagnostics	Blood Borne Pathogens
21/330	Influenza Antigen B/Michigan/01/2021 (B/Victoria Lineage)	Vaccines	Influenza
21/332	1st International Reference Panel for anti-Lassa fever virus antibodies	Vaccines	Influenza
21/336	Influenza Virus Infectious B/Washington/02/2019 (B-Victoria lineage)	Diagnostics	Protein Hormones and Endocrine Products
21/338	1st International Standard 2022 Antibodies to SARS-CoV-2 variants of concern	Diagnostics	Protein Hormones and Endocrine Products
21/340	Second WHO International Standard for anti-SARS-CoV-2 immunoglobulin.	Diagnostics	Quality Control Reagent (D)
21/346	Influenza Virus Infectious A/Victoria/2570/2019 (H1N1)	Diagnostics	Quality Control Reagent (D)
21/348	Influenza Virus Infectious B/Utah/9/2014 (B-Yamagata lineage)	Diagnostics	Quality Control Reagent (D)
21/350	Influenza Virus Infectious BX-59A (B-Yamagata lineage)	Diagnostics	Quality Control Reagent (D)
21/352	Influenza Virus Infectious B/Brisbane/9/2014 (B-Yamagata)	Diagnostics	Parasitology
21/366	Influenza Virus Infectious SAN-011 (H1N1)	Diagnostics	Parasitology
21/368	SARS-Cov-2 Antigen 1st WHO International Standard	Biotherapeutics	Haemostasis
21/378	Anti-human leukocyte antigen antibodies (weak positive plasma)	Diagnostics	Blood Borne Pathogens
21/380	Influenza Virus Infectious IVR-208 (H3N2)	Vaccines	Influenza
21/382	Influenza Virus Infectious X-367A (H3N2)	Biotherapeutics	Haemostasis
21/382	Influenza Virus Infectious X-367A (H3N2)	Vaccines	Influenza
21/384	Influenza Virus Infectious X-369A (H3N2)	Vaccines	Influenza
21/384	Influenza Virus Infectious X-369A (H3N2)	Biotherapeutics	Haemostasis
21/388	Influenza Virus Infectious B/Guangdong-Zhenjiang/1516/2021 (B-Victoria Lineage)	Vaccines	Emerging Viruses (V)
21/388	Influenza Virus Infectious B/Guangdong-Zhenjiang/1516/2021 (B-Victoria Lineage)	Vaccines	Emerging Viruses (V)
22/100	Influenza Antigen A/Victoria/2570/2019 (IVR-215) (H1N1)	Biotherapeutics	Immunoglobulins and Immune Sera
22/104_BA	1st International Standard 2023 Rift Valley fever virus antibodies for binding assays (Human Plasma)	Diagnostics	Blood Transfusion and Transplantation
22/104_NT	1st International Standard 2023 Rift Valley fever virus antibodies for neutralisation assays (Human Plasma)	Vaccines	Emerging Viruses (V)
22/108	Reference Panel for Lassa virus RNA	Vaccines	Tetanus
22/118	Influenza Virus Infectious NIB-129 (H3N2)	Diagnostics	Blood Borne Pathogens
22/120	5th WHO International Standard, Hepatitis B Virus DNA for NAT	Vaccines	Influenza
22/134	Influenza Virus Infectious BX-107A (B-Victoria Lineage)	Vaccines	Influenza
22/136	Influenza Virus Infectious A/North Carolina/01/2021 (H1N1) X-375	Vaccines	Influenza
22/136	Influenza Virus Infectious A/North Carolina/01/2021 (H1N1) X-375	Vaccines	Influenza
22/138	Influenza Virus Infectious A/Indiana/02/2020 (H1N1)	Vaccines	Immunoglobulins and Immune Sera
22/140	Influenza Virus Infectious A/Netherlands 00007/2021 (H3N2) SAN-012	Vaccines	Influenza
22/140	Influenza Virus Infectious A/Netherlands 00007/2021 (H3N2) SAN-012	Biotherapeutics	Immunoglobulins and Immune Sera
22/142	Influenza Virus Infectious A/Sydney/5/2021 (H1N1) SAN-013	Vaccines	Influenza
22/144	Influenza Virus Infectious A/Darwin/22/2021 (H3N2) SAN-014	Vaccines	Influenza
22/144	Influenza Virus Infectious A/Darwin/22/2021 (H3N2) SAN-014	Vaccines	Influenza
22/146	Influenza Virus Infectious A/Brisbane/02/2018 (H1N1)	Diagnostics	Genomic Reference Material
22/146	Influenza Virus Infectious A/Brisbane/02/2018 (H1N1)	Vaccines	Influenza
22/148	Meningococcal Capsular Group Y Polysaccharide	Vaccines	Influenza
22/154	Influenza Virus Infectious B/Connecticut/01/2021 (B-Victoria Lineage)	Diagnostics	Blood Borne Pathogens
22/154	Influenza Virus Infectious B/Connecticut/01/2021 (B-Victoria Lineage)	Diagnostics	Blood Borne Pathogens
22/156	Influenza Virus Infectious A/Norway/16606/2021 (H3N2) NYMC X-373A	Vaccines	Influenza
22/156	Influenza Virus Infectious A/Norway/16606/2021 (H3N2) NYMC X-373A	Vaccines	Meningococcal Reagents
22/158	Influenza Virus Infectious A/Netherlands/00007/2021 (H3N2) NYMC X-377	Vaccines	Rabies
22/158	Influenza Virus Infectious A/Netherlands/00007/2021 (H3N2) NYMC X-377	Vaccines	Polio
22/172	Influenza Virus Infectious A/Lyon/820/2021 (H1N1) NIB-132	Vaccines	Influenza
22/174	Influenza Virus Infectious A/Victoria/2570/2019 (H1N1) NYMC X-379	Vaccines	Polio
22/178	Influenza Virus Infectious A/Darwin/22/2021 (H3N2) NIB -130	Diagnostics	Blood Borne Pathogens
22/178	Influenza Virus Infectious A/Darwin/22/2021 (H3N2) NIB -130	Vaccines	Influenza
22/180	Influenza Virus Infectious A/Guizhou/Liuzhite/326/2022 (H3N2) CNIC-2206	Diagnostics	Protein Hormones and Endocrine Products
22/180	Influenza Virus Infectious A/Guizhou/Liuzhite/326/2022 (H3N2) CNIC-2206	Vaccines	Influenza
22/200	Influenza Virus Infectious A/Sydney/5/2021 (H1N1)	Biotherapeutics	Monoclonal Antibodies
22/204	Influenza Virus Infectious B/Austria/1359之417/2021 (B-Victoria lineage) BVR-26	Vaccines	Polio
22/214	Influenza Virus Infectious CBER-48A (A/Sydney/5/2021) (H1N1)	Vaccines	Meningococcal Reagents
22/220	Influenza Antigen A/Sydney/5/2021 (SAN-013) (H1N1)	Vaccines	Enteric disease
22/222	Influenza Antigen A/Sydney/175/2022 (IVR-235) (H1N1)	Vaccines	Enteric disease
22/226	Influenza Anti-A/Darwin/9/2021-Like (H3N2) HA Serum	Diagnostics	Genomic Reference Material
22/228	Influenza Anti-B/Austria/1359之417/2021-like (B Victoria lineage) HA Serum	Vaccines	Influenza
22/234	Influenza Virus Infectious IVR-235 (A/Sydney/175/2022 (H1N1)	Vaccines	Influenza
22/234	Influenza Virus Infectious IVR-235 (A/Sydney/175/2022 (H1N1)	Diagnostics	Emerging Viruses (D)
22/236	Anti-pneumococcal serotype 2 monoclonal antibody (clone 2D1)	Vaccines	Influenza
22/238	Anti-pneumococcal serotype 4 monoclonal antibody (clone 14-100JA2 IIE7 2H7)	Vaccines	Influenza
22/240	Anti-pneumococcal serotype 6B monoclonal antibody (clone 14-102GA3 ID10 1B10)	Diagnostics	Quality Control Reagent (D)
22/242	Anti-pneumococcal serotype 11A monoclonal antibody (clone 8G12)	Diagnostics	Quality Control Reagent (D)
22/244	Anti-pneumococcal serotype 15B monoclonal antibody (clone 3D3)	Diagnostics	Quality Control Reagent (D)
22/246	Anti-pneumococcal serotype 17F monoclonal antibody (clone 17-120DG2 IF2)	Diagnostics	Quality Control Reagent (D)
22/248	Anti-pneumococcal serotype 20 monoclonal antibody (clone 18-121 DF9 IIG8 1B6)	Diagnostics	Quality Control Reagent (D)
22/250	Anti-pneumococcal serotype 33F monoclonal antibody (clone 3B2)	Biotherapeutics	Protein Hormones and Endocrine Products
22/254	Anti-pneumococcal serotype 6C monoclonal antibody (clone 1B2)	Vaccines	Influenza
22/256	Anti-pneumococcal serotype 15A/B monoclonal antibody (clone 3A4)	Vaccines	Influenza
22/258	Anti-pneumococcal serotype 16F monoclonal antibody (clone 20-121HC4 IA4 IE6)	Vaccines	Polio
22/260	Anti-pneumococcal serotype 19F monoclonal antibody (clone 8E9- 1B12)	Vaccines	Influenza
22/262	Anti-pneumococcal serotype 23F monoclonal antibody (clone 15-113HA6 IG2)	Diagnostics	Blood Borne Pathogens
22/264	Anti-pneumococcal serotype 24F monoclonal antibody (clone 1A6)	Biotherapeutics	Cell Reference Material
22/266	Anti-pneumococcal serotype 35B monoclonal antibody (clone 3F6)	Biotherapeutics	Cell Reference Material
22/268	Influenza Virus Infectious SAN-015 (A/Lyon/820/2021) (H1N1)	Diagnostics	Blood Transfusion and Transplantation
22/270	1st International Reference Panel for antibodies to SARS-CoV-2 variants of concern	Vaccines	Emerging Viruses (V)
22/272	1st International Reference Panel for Infliximab anti-drug antibodies	Vaccines	Influenza
22/274	Influenza Virus Infectious IVR-215 (A/Victoria/2570/2019) (H1N1)	Vaccines	Influenza
22/276	Anti-pneumococcal serotype 2 monoclonal antibody (clone 1G7)	Biotherapeutics	Immunogenicity
22/278	Anti-pneumococcal serotype 15B monoclonal antibody (clone 2F4)	Biotherapeutics	Immunogenicity
22/280	Anti-pneumococcal serotype 23F monoclonal antibody (clone 15-113HA5 IE2 IE2)	Vaccines	Influenza
22/282	Anti-pneumococcal serotype 24F monoclonal antibody (clone 2F2)	Vaccines	Influenza
22/284	Anti-pneumococcal serotype CPS monoclonal antibody (clone 14-108BA5 IE10)	Diagnostics	Ebola Virus
22/286	Anti-pneumococcal serotype 4 monoclonal antibody (clone 14-100JA2 IIE7 2G6)	Diagnostics	Ebola Virus
22/288	Anti-pneumococcal serotype 5 monoclonal antibody (clone 1366KG3 IA11)	Vaccines	Emerging Viruses (V)
22/290	Anti-pneumococcal serotype 6B monoclonal antibody (clone 14-102CC2 ID9)	Vaccines	Influenza
22/292	Anti-pneumococcal serotype 8 monoclonal antibody (clone 6G1)	Vaccines	Influenza
22/294	Anti-pneumococcal serotype 10A monoclonal antibody (clone 17-117DE8 IIE9)	Vaccines	Influenza
22/296	Anti-pneumococcal serotype 11A monoclonal antibody (clone 2E2)	Vaccines	Influenza
22/298	Anti-pneumococcal serotype 12F monoclonal antibody (clone 1C8)	Vaccines	Influenza
22/300	Anti-pneumococcal serotype 15A-B monoclonal antibody (clone 1B4)	Biotherapeutics	Haemostasis
22/302	Anti-pneumococcal serotype 16F monoclonal antibody (clone 20-121EC11 IIF10 VE2)	Diagnostics	Haemostasis (D)
22/304	Anti-pneumococcal serotype 17F monoclonal antibody (clone 17-120AE4 IE3 IG2)	Diagnostics	Immunoglobulins and Immune Sera
22/306	Anti-pneumococcal serotype 22F monoclonal antibody (clone 17-122 JB11 IB11)	Vaccines	Influenza
22/308	Anti-pneumococcal serotype 35B monoclonal antibody (clone 3F9)	Vaccines	Influenza
22/312	Influenza Virus Infectious A/Norway/31694/2022 (H1N1)	Vaccines	Influenza
22/316	Influenza Virus Infectious A/Victoria/4897/2022 (H1N1)	Vaccines	Influenza
22/318	Influenza Virus Infectious IVR-238 (A/Victoria/4897/2022 (H1N1)	Biotherapeutics	Haemostasis
22/320	Influenza Antigen A/Victoria/4897/2022 (IVR-238) (H1N1)	Diagnostics	Ebola Virus
23/100	Influenza anti-A/Victoria/4897/2022-like (H1N1) HA Serum	Diagnostics	Ebola Virus
23/106	Methylated Human Serum Albumin (mHSA)	Vaccines	Influenza
23/112	Influenza Virus Infectious NIB-133 (A/Norway/31694/2022) (H1N1)	Vaccines	Influenza
23/114	Influenza Virus Infectious SAN-010 (A/Darwin/09/2021) (H3N2)	Diagnostics	Quality Control Reagent (D)
23/116	Influenza Virus Infectious SAN-018 (A/Maryland/02/2021) (H3N2)	Vaccines	Pertussis
23/118	Influenza Virus Infectious SAN-019 (A/Alaska/01/2021) (H3N2)	Biotherapeutics	Haemostasis
23/120	Influenza Virus Infectious A/Wisconsin/67/2022 (H1N1)	Vaccines	Influenza
23/122	Influenza Virus Infectious A/West Virginia/30/2022 (H1N1)	Biotherapeutics	Haemostasis
23/126	Influenza Virus Infectious NIB-134 (A/Catalonia/NSVH161512065/2022 (H1N1)	Vaccines	Influenza
23/132	Influenza Virus Infectious NYMC BX-117 (B/Zhejiang-Nanhu/1854/2021) (B-Victoria lineage)	Diagnostics	Quality Control Reagent (D)
23/134	Influenza Virus Infectious NYMC X-387 (A/Maryland/02/2021) (H3N2)	Diagnostics	Quality Control Reagent (D)
23/136	Influenza Virus Infectious NYMC X-391 (A/Guizhou-Liuhite/326/2021) (H3N2)	Diagnostics	Quality Control Reagent (D)
23/138	Influenza Virus Infectious NYMC X-391A (A/Guizhou-Liuzhite/326/2021) (H3N2)	Diagnostics	Quality Control Reagent (D)
23/142	Anti-Meningococcal Human Reference Serum Group B	Vaccines	Influenza
23/150	Bordetella Pertussis 18323 coating antigen	Vaccines	Influenza
23/152	Influenza Virus Infectious NYMC X-393 (A/West Virginia/30/2022) (H1N1)	Biotherapeutics	Haemostasis
23/154	Influenza Virus Infectious NYMC X-393A (A/West Virginia/30/2022) (H1N1)	Vaccines	Influenza
23/156	Influenza Virus Infectious NYMC BX-115 (B/Zhejiang-Xiacheng/11085/2021 (B/Victoria lineage)	Vaccines	Influenza
2BADS	Anti-Brucella Abortus Serum, Bovine (International Standard)	Vaccines	Influenza
2CPBETAAT	Clostridium Perfringens Beta Antitoxin (2nd International Standard)	Diagnostics	Blood Transfusion and Transplantation
2CPEPAT	Clostridium Perfringens Epsilon Antitoxin (2nd International Standard)	Vaccines	Influenza
32-1	Filamentous Haemagglutinin monoclonal antibody, clone 32-1	Diagnostics	Human Papillomavirus
3-5	Pertactin Monoclonal antibody, Clone 3-5	Diagnostics	Human Papillomavirus
520	IPV ELISA MAbs Type 1, 2 and 3 (Type 3; No: 520)	Diagnostics	Human Papillomavirus
59/015	Gas Gangrene (Cl. Perfringens(Cl. Welchii) Type A), Equine	Diagnostics	Human Papillomavirus
59/016	Corticotrophin (ACTH), Porcine (3rd International Standard)	Diagnostics	Human Papillomavirus
59/021	Botulinum Antitoxin Equine Type A	Vaccines	Influenza
60/001	Botulinum Antitoxin Equine Type B	Biotherapeutics	Haemostasis
60/013	Tetanus Antitoxin, Equine, for Bioassay	Vaccines	Influenza
62/014	Lysine Vasopressin, Porcine	Vaccines	Influenza
629E1	Pertussis toxoid monoclonal antibody, clone 629E1	Vaccines	Influenza
63/005	Gas Gangrene Antitoxin (Cl. Histolyticum), Equine	Vaccines	Influenza
64/003	Rheumatoid Arthritis Serum Human	Vaccines	Influenza
64/014	Gas Gangrene Antitoxin (Cl. Septicum), Equine	Diagnostics	Blood Transfusion and Transplantation
64/024	Gas Gangrene Antitoxin (Cl. Oedematiens), Equine	Biotherapeutics	Monoclonal Antibodies
65/093	Anti-Thyroglobulin Serum, Human (WHO Reference reagent)	Vaccines	Influenza
65/093	Anti-Thyroglobulin Serum, Human (WHO Reference reagent)	Vaccines	Influenza
65/119	Renin, Porcine	Diagnostics	Blood Borne Pathogens
65/122	Long-acting Thyroid Stimulator, Human	Diagnostics	Blood Borne Pathogens
66/138	Gastrin II, Porcine	Vaccines	Botulinum
66/153	Diphtheria Antitoxin, Equine	Biotherapeutics	Immunoglobulins and Immune Sera
66/233	Anti-Nuclear Factor Serum (Homogenous) Human	Vaccines	Meningococcal Reagents
67/037	Immunoglobulin D (IgD) Serum, Human	Biotherapeutics	Haemostasis
67/099	Immunoglobulins G, A & M Serum Human	Vaccines	Influenza
67/183	Primary Biliary Cirrhosis Serum, Human	Vaccines	Influenza
68/340	Anti-Nucleolar Factor Plasma, Human	Vaccines	Entero Virus
68/356	Renin, Human (International Standard)	Vaccines	Influenza
69/065	Autoimmune Antibody to Human Spermatazoa	Vaccines	Influenza
69/194	Glucagon, Porcine (First International Standard)	Diagnostics	Blood Transfusion and Transplantation
69K/16	Pertactin monoclonal antibody, clone 69K/16	Vaccines	Influenza
70/302	Angiotensin II (25µg)	Diagnostics	Human Papillomavirus
71/281	Anti-Malaria Plasma P Vivax	Diagnostics	Human Papillomavirus
71/326	Anti-Malaria Plasma Vivax Ng2	Diagnostics	Quality Control Reagent (D)
72/092	Anti-malaria Plasma: Plasmodium falciparum (Ghana)	Diagnostics	Quality Control Reagent (D)
72/096	Anti-Malaria Serum (P.Malariae)	Diagnostics	Quality Control Reagent (D)
72/341	Anti-Malaria Plasma P Falciparum	Diagnostics	Quality Control Reagent (D)
72/345	Anti-Malaria Plasma P Falciparum	Diagnostics	Quality Control Reagent (D)
72/348	Anti-Malaria Plasma P Vivax	Diagnostics	Quality Control Reagent (D)
73/517	Anti-D (Rho) Antibodies, Human	Vaccines	Influenza
73/545	Placental Lactogen, Human (International Reference Preparation)	Vaccines	Meningococcal Reagents
73/554	Cholera Vaccine (Inaba)	Vaccines	Influenza
73/556	Cholera Vaccine (Ogawa)	Vaccines	Influenza
73/601	Carcinoembryonic Antigen (CEA), Human (1st International Reference Preparation)	Vaccines	Influenza
74/520	Serum Proteins (Other than Immunoglobulins) Human	Vaccines	Influenza
74/581	Ancrod (1st International Reference Preparation)	Vaccines	Influenza
75/506	Cocksfoot Pollen Extract	Vaccines	Meningococcal Reagents
75/533	Chorionic Gonadotrophin, Human, for Radioiodination	Biotherapeutics	Haemostasis
75/535	Chorionic Gonadotrophin beta, Human, for Radioiodination	Vaccines	Tetanus
75/551	Chorionic Gonadotrophin beta Subunit, Human (International Reference Preparation)	Vaccines	Entero Virus
75/569	Chorionic Gonadotrophin alpha subunit, Human (International Reference Preparation)	Vaccines	Influenza
75/595	Blood Coagulation Factor Xa, Bovine	Vaccines	Influenza
76/508	Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination	Vaccines	Influenza
76/515	Mannan (Candida Albicans) Purified	Vaccines	Polio
76/525	Anti-Birch Pollen Serum, Human	Vaccines	Polio
76/547	Influenza anti A/Victoria/3/75 Serum(goat)	Vaccines	Polio
76/575	Oxytocin(4th International Standard)	Vaccines	Polio
77/503	Anti-Cocksfoot Serum, Human	Vaccines	Polio
77/512	Lysine Vasopressin(1st International Standard)	Vaccines	Polio
77/531	Influenza anti A/New Jersey/8/76(H1N1) Serum	Vaccines	Meningococcal Reagents
77/568	Influenza anti B/Hong Kong/8/73 Serum	Diagnostics	Blood Borne Pathogens
77/584	Anti-D Pteronyssinus Serum, Human	Vaccines	Diphtheria
77/600	Mannan (Candida Albicans) Purified	Biotherapeutics	Haemostasis
77/616	Twelve Grass Pollen Extract	Biotherapeutics	Cytokines and Growth Factors
77/643	Secretin	Vaccines	Influenza
77/662	Acarus Siro Extract	Vaccines	Influenza
77/664	Glycyphagus destructor Extract	Vaccines	Influenza
78/517	Tyrophagus Putrescentiae Extract	Vaccines	Influenza
78/543	Kininogenase (Porcine, Pancreatic) (Formerly 1st International Standard)	Vaccines	Influenza
78/545	Anti-Aspergillus fumigatus Serum, Human	Diagnostics	Haemostasis (D)
78/554	Luteinizing Hormone, Pituitary, alpha subunit (International Standard)	Diagnostics	Quality Control Reagent (D)
78/556	Luteinizing Hormone, Pituitary, beta subunit (International standard)	Vaccines	Influenza
78/560	Influenza Antigen A/Texas/1/77	Vaccines	Influenza
78/569	Influenza anti A/Texas/1/77 Serum	Vaccines	Influenza
78/575	Aspergillus Fumigatus Extract	Vaccines	Influenza
78/582	Tyrophagus Longior Extract	Biotherapeutics	Immunoglobulins and Immune Sera
78/628	Bee Venom	Diagnostics	Protein Hormones and Endocrine Products
79/500	Parathyroid Hormone, HumanRef. Preparation)	Vaccines	Influenza
79/516	Influenza anti A/Brazil/11/78 Serum (goat)	Diagnostics	Parasitology
79/552	Influenza Antigen A/USSR/92/77	Vaccines	Influenza
79/558	Influenza Antigen A/USSR/92/77	Vaccines	Influenza
79/560	Influenza Antigen A/Brazil/11/78	Biotherapeutics	Immunogenicity
79/568	Influenza Antigen B/Hong Kong/8/73	Vaccines	Influenza
79/572	Prekallikrein Activator (PKA), Human	Vaccines	Influenza
80/505	Growth Hormone, Human, Pituitary. WHO International Standard	Vaccines	Meningococcal Reagents
80/517	Influenza Antigen A/Bangkok/1/79	Vaccines	Influenza
80/519	Influenza Antigen B/Singapore/222/79	Biotherapeutics	Haemostasis
80/523	Influenza anti B/Singapore/222/79 Serum	Diagnostics	Quality Control Reagent (D)
80/525	Influenza anti A/Bangkok/1/79 Serum	Vaccines	Haemophilus Influenzae type b (Hib)
80/590	Tetracosactide. International Ref. Preparation	Biotherapeutics	Immunoglobulins and Immune Sera
81/535	Luteinizing Hormone, Human, Pituitary (3rd International Standard)	Vaccines	Influenza
82/508	Parathyroid Hormone, Human-Type, Synthetic (1-34) fragment	Vaccines	Influenza
82/512	Parathyroid Hormone, Bovine-Type, Synthetic (1-34) fragment	Vaccines	Meningococcal Reagents
82/518	Dermatophagoides Pteronyssinus Extract. WHO International Standard	Vaccines	Diphtheria
82/520	Timothy Pollen Extract. WHO International Standard	Vaccines	Pneumococcal vaccines
82/585	Anti Poliovirus serum types 1,2 and 3 (3rd International Standard)	Diagnostics	Haemostasis (D)
82/587	Interferon Gamma (Human, Leukocyte derived)	Vaccines	Influenza
82/632	Parathyroid Hormone, Bovine. WHO International Standard	Vaccines	Enteric disease
82/652	Human Serum Vitamin B12, Pernicous anaemia	Diagnostics	Blood Borne Pathogens
83/501	Beta Thromboglobulin, Purified Human. WHO International Standard	Diagnostics	Blood Borne Pathogens
83/505	Platelet Factor 4 Human, Purified. WHO International Standard	Diagnostics	Parvovirus
83/511	Insulin, Bovine. WHO International Standard	Vaccines	Influenza
83/514	Interferon alpha-1D, (Human rDNA derived) WHO International Standard	Vaccines	Influenza
83/515	Insulin, Porcine. WHO International Standard	Vaccines	Influenza
83/537	Influenza Antigen A/Philippines/2/82	Biotherapeutics	Cytokines and Growth Factors
83/545	Influenza anti A/Philippine/2/82 Serum	Biotherapeutics	Cytokines and Growth Factors
83/550	Influenza Antigen A/Brazil/11/78	Vaccines	Influenza
83/573	Prolactin, Human (4th WHO International Standard.)	Vaccines	Influenza
83/575	Follicle Stimulating Hormone, Pituitary. WHO International Standard	Vaccines	Influenza
84/514	Proinsulin, Bovine. International Ref. Preparation	Vaccines	Influenza
84/522	Birch Pollen Extract. WHO International Standard	Vaccines	Influenza
84/528	Proinsulin, Porcine. International Ref. Reagent	Vaccines	Influenza
84/538	Influenza Antigen A/Chile/1/83	Vaccines	Influenza
84/542	Influenza Antigen B/Norway/1/84	Vaccines	Polio
84/581	Short Ragweed Pollen Extract. WHO International Standard	Vaccines	Influenza
84/614	Calcitonin, ASU 1-7 Eel Calcitonin Analogue (Elcatonin) WHO International Standard	Diagnostics	Quality Control Reagent (D)
84/628	Anti-c Serum, Human	Vaccines	Influenza
84/636	Influenza anti B/USSR/100/83 Serum	Vaccines	Quality Control Reagent (V)
84/640	Influenza anti A/Chile/1/8 Serum	Diagnostics	Immunoglobulins and Immune Sera
84/677	Influenza anti A/equine/Miami/63 (H3N8) Serum(goat)	Vaccines	Influenza
84/685	Dog (Canis Familiaris) Hair Dander Extract. WHO International Standard	Vaccines	Influenza
85/506	C-Reactive Protein, Human. WHO International Standard	Diagnostics	Parasitology
85/516	Influenza anti A/Equine/Kentucky/1/81 HA Serum	Diagnostics	Blood Transfusion and Transplantation
85/520	Influenza Antigen A/Equine/Kentucky/1/81	Diagnostics	Protein Hormones and Endocrine Products
85/522	Thyroid Stimulating Hormone beta subunit	Biotherapeutics	Monoclonal Antibodies
85/551	Anti-Rye Grass Serum, Human	Vaccines	Influenza
85/616	Haemoglobin F Lysate, Raised. WHO Reference Reagent	Vaccines	Influenza
85/669	Atrial Natriuretic Factor, Human. WHO International Standard	Biotherapeutics	Haemostasis
86/500	Interleukin- 2 (Human, rDNA derived)(2nd International Standard)	Biotherapeutics	Haemostasis
86/536	Angiotensin I Human Type Synthetic	Biotherapeutics	Protein Hormones and Endocrine Products
86/538	Angiotensin II (2.5µg)	Vaccines	Influenza
86/552	Interleukin-1 Beta (Human, rDNA derived)	Biotherapeutics	Haemostasis
86/576	Influenza Antigen A/Mississippi/1/85	Vaccines	Influenza
86/590	Influenza anti A/Mississippi/1/85 Serum	Biotherapeutics	Protein Hormones and Endocrine Products
86/592	Influenza anti B/Ann Arbor/1/86/HA Serum	Vaccines	Tuberculosis (V)
86/630	Influenza Antigen B/Ann Arbor/ 1/86	Vaccines	Diphtheria
86/632	Interleukin-1 alpha (Human rDNA derived) WHO International Standard	Vaccines	Influenza
86/678	Interleukin-1 alpha (Human, rDNA derived)	Biotherapeutics	Haemostasis
86/680	Interleukin-1 beta (Human, rDNA derived) WHO International Standard	Diagnostics	Parasitology
86/690	Inhibin, Porcine WHO International Standard	Diagnostics	Blood Transfusion and Transplantation
87/510	Influenza Antigen A/Equine/Miami/63	Diagnostics	Blood Transfusion and Transplantation
87/578	Influenza anti A/Leningrad/360/86 Serum	Diagnostics	Blood Transfusion and Transplantation
87/584	Influenza Antigen A/Leningrad/360/86	Diagnostics	Blood Transfusion and Transplantation
87/586	Interferon Gamma (Human, rDNA derived)	Vaccines	Influenza
87/640	Tumour Necrosis Factor beta (Human, rDNA derived) WHO Reference Reagent	Vaccines	Influenza
87/654	Anti-Ferritin Monoclonal Antibody (1)	Vaccines	Influenza
87/662	Anti-Ferritin Monoclonal Antibody (2)	Vaccines	Influenza
87/714	Influenza Antigen A/Sichuan/2/87	Vaccines	Parasitology
87/774	Influenza Antigen B/Victoria/2/87	Biotherapeutics	Endotoxin
88/522	Bordetella pertussis (Whole cell vaccine) 3BRP	Biotherapeutics	Cytokines and Growth Factors
88/532	Tumour Necrosis Factor alpha (Mouse, rDNA derived)	Vaccines	Polio
88/554	Influenza Antigen B/Beijing/1/87	Vaccines	Polio
88/556	Calcitonin, Eel WHO International Standard	Vaccines	Polio
88/638	Thyroxine-binding globulin. WHO International Standard	Vaccines	Polio
88/646	Granulocyte Macrophage Colony Stimulating Factor (Human, rDNA derived) WHO International Standard	Biotherapeutics	Blood Transfusion and Transplantation
88/654	Influenza Antigen A/England/427/88	Vaccines	Human Papillomavirus
88/656	Interleukin-4 (Human, rDNA derived) WHO International Standard	Vaccines	Tetanus
88/672	Influenza anti A/Sichuan/2/87 Serum	Vaccines	Tetanus
88/678	Influenza anti B/Beijing/1/87 Serum	Vaccines	Diphtheria
88/846	Influenza anti A/England/427/88 Serum	Vaccines	Diphtheria
89/512	Macrophage Colony Stimulating Factor (CSF-1) (Human rDNA derived) WHO International Standard	Vaccines	Influenza
89/514	Transforming Growth Factor beta-1 (Human, rDNA derived)	Biotherapeutics	Haemostasis
89/516	Transforming Growth Factor beta-1 (Bovine)	Vaccines	Influenza
89/518	Transforming Growth Factor beta-2 (Bovine)	Vaccines	Influenza
89/520	Interleukin-8 (Human, rDNA derived) WHO International Standard	Vaccines	Influenza
89/530	Anti-Bordetella pertussis serum (Human)	Diagnostics	Protein Hormones and Endocrine Products
89/544	Renin, Human, rec DNA	Diagnostics	Blood Transfusion and Transplantation
89/568	Influenza Antigen A/OMS/5389/88	Vaccines	Influenza
89/594	Bordetella pertussis (W28) LPS 2ug	Vaccines	Influenza
89/596	Bordetella pertussis anti-agglutinogen 1(rabbit)	Biotherapeutics	Cytokines and Growth Factors
89/598	Bordetella pertussis anti-agglutinogen 2 (rabbit)	Vaccines	Influenza
89/600	Bordetella pertussis anti-agglutinogen 3 (rabbit)	Biotherapeutics	Cytokines and Growth Factors
89/620	Calcitonin, Human. WHO International Standard	Biotherapeutics	Haemostasis
89/666	Haemoglobin A2 Lysate, Raised. WHO Reference Reagent	Diagnostics	Blood Transfusion and Transplantation
89/670	Bordetella pertussis (W28) LPS25ug	Biotherapeutics	Haemostasis
8E1-1H1.2.1	Tetanus toxoid monoclonal antibody, clone 8E1-1H1.2.1	Vaccines	Influenza
90/500	Influenza Antigen A/Shanghai/16/89	Biotherapeutics	Cytokines and Growth Factors
90/502	Influenza Antigen A/Guizhou/54/89	Vaccines	Haemophilus Influenzae type b (Hib)
90/504	Influenza anti A/Guangdong/39/89 Serum	Vaccines	Influenza
90/520	Bordetella pertussis, filamentous haemagglutinin (FHA)	Diagnostics	Parasitology
90/530	Interleukin-7 (Human, rDNA derived) WHO Reference Reagent	Diagnostics	Parasitology
90/534	Mumps Vaccine (Live) WHO Reference Reagent	Vaccines	Influenza
90/586	Interleukin-5 (Human, rDNA derived) WHO Reference Reagent	Biotherapeutics	Haemostasis
90/636	HIV-1 P24 Antigen WHO International Standard	Vaccines	Influenza
90/690	Anti-Varicella-Zoster Antibody	Diagnostics	Haemostasis (D)
90/696	Transforming Growth Factor beta-2, Human, rec DNA	Vaccines	Meningococcal Reagents
90/712	Basic Fibroblast Growth Factor (Human, rDNA derived) WHO International Standard	Diagnostics	Blood Transfusion and Transplantation
90/784	Influenza Virus infectious NIB-26 (H3N2)	Vaccines	Influenza
91/510	Interleukin-3 (Human, rDNA derived) WHO International Standard	Diagnostics	Genomic Reference Material
91/530	Epidermal Growth Factor (Human, rDNA derived) WHO International Standard	Diagnostics	Genomic Reference Material
91/550	Epidermal Growth Factor (1-52) (Human, rDNA derived) WHO Reference Reagent	Biotherapeutics	Cytokines and Growth Factors
91/554	Insulin-like growth Factor 1 WHO International Standard	Vaccines	Influenza
91/612	Influenza anti A/Taiwan/1/86 Serum	Diagnostics	Blood Borne Pathogens
91/624	Recombinant Human Inhibin	Vaccines	Influenza
91/626	Activin A, Human, Recombinant. WHO Reference Reagent	Vaccines	Influenza
91/656	Interleukin-4 (Mouse, rDNA derived)	Vaccines	Influenza
91/658	Granulocyte Macrophage Colony Stimulating Factor (Mouse rDNA derived)	Diagnostics	Quality Control Reagent (D)
91/662	Interleukin-3 (Mouse, rDNA derived)	Diagnostics	Quality Control Reagent (D)
91/670	Influenza Virus infectious NIB-27 (H1N1)	Vaccines	Influenza
91/678	Interleukin-9 (Human,rDNA derived) WHO Reference Reagent	Vaccines	Influenza
91/682	Stem Cell Factor (Human rDNA derived) WHO Reference Reagent	Vaccines	Influenza
91/688	1st International Reference Reagent Rubella Vaccine (Live)	Vaccines	Influenza
92/510	Follicle Stimulating Hormone, Human, recombinant. (WHO International Standard)	Vaccines	Influenza
92/512	Follicle Stimulating Hormone, urofollitropin Human Urinary WHO International Standard	Diagnostics	Protein Hormones and Endocrine Products
92/518	Macrophage Inflammatory Protein-1 alpha (Human, rDNA derived)	Diagnostics	Haemostasis (D)
92/520	Rantes (Human, rDNA derived)	Diagnostics	Haemostasis (D)
92/530	Influenza Antigen A/Texas/36/91	Biotherapeutics	Haemostasis
92/582	Influenza anti B/Yamagata/16/88 Serum	Vaccines	Influenza
92/628	Influenza Antigen B/Yamagata/16/88	Catalogue	Influenza
92/632	Influenza anti A/Beijing/352/89 (H3N2) Serum	Vaccines	Influenza
92/644	Interleukin-1 Receptor Antagonist (IL-1ra) (Human, rDNA derived)	Vaccines	Influenza
92/648	Measles Vaccine (Live) 2nd International Reference Reagent	Biotherapeutics	Haemostasis
92/654	Plasminogen Activator Inhibitor-1 (PAI-1), plasma Human WHO International Standard	Vaccines	Influenza
92/658	Papain preparation for use with Anti-D preparation 91/562	Vaccines	Tetanus
92/734	Influenza Virus infectious A/Beijing/32/92 (H3N2)	Vaccines	Influenza
92/738	Influenza Virus infectious A/Shanghai/24/90	Vaccines	Influenza
92/788	Interleukin-11 (Human, rDNA derived) WHO Reference Reagent	Vaccines	Influenza
92/794	Monocyte Chemoattractant Protein-1 (Human,rDNA derived)	Diagnostics	Protein Hormones and Endocrine Products
93/500	Influenza Antigen A/Beijing/32/92	Vaccines	Influenza
93/516	Influenza Antigen A/Shanghai/24/90	Vaccines	Influenza
93/518	Influenza anti A/Beijing/32/92 (H3N2) Serum	Diagnostics	Quality Control Reagent (D)
93/522	Influenza anti A/Shanghai/24/90 (H3N2) Serum	Diagnostics	Genomic Reference Material
93/556	Nerve Growth Factor (Human, rDNA derived) WHO Reference Reagent	Diagnostics	Genomic Reference Material
93/560	Insulin-like growth Factor Binding Protein-3	Vaccines	Influenza
93/562	Leukaemia Inhibitory Factor (Human, rDNA derived) WHO Reference Reagent	Vaccines	Influenza
93/564	Oncostatin M (Human, rDNA derived) WHO Reference Reagent	Vaccines	Influenza
93/566	Interleukin-2 (Mouse, rDNA derived)	Vaccines	Influenza
93/568	Influenza Virus infectious A/Beijing/359/89 (H3N2)	Vaccines	Influenza
93/574	Bone morphogenetic Protein-2 (Human, rDNA derived) WHO Reference Reagent	Vaccines	Influenza
93/668	Interleukin-1 beta (Mouse, rDNA derived)	Vaccines	Influenza
93/672	Interleukin-1 alpha (Mouse, rDNA derived)	Vaccines	Influenza
93/692	Influenza Virus infectious B/Panama/45/90	Diagnostics	Quality Control Reagent (D)
93/722	Interleukin-10 (Human rDNA derived) WHO Reference Reagent	Vaccines	Influenza
93/730	Interleukin-6 (Mouse, rDNA derived)	Vaccines	Influenza
93/740	Interleukin-7 (Mouse, rDNA derived)	Biotherapeutics	Haemostasis
93/816	Influenza Virus infectious A/Harbin/15/92 (H3N2)	Vaccines	Influenza
94/500	Influenza Antigen B/Panama/45/90	Vaccines	Influenza
94/504	Influenza anti A/Shanghai/9/93 Serum	Vaccines	Influenza
94/516	Influenza Antigen A/Shangdong/9/93	Biotherapeutics	Haemostasis
94/520	Influenza anti B/Panama/45/90 Serum	Vaccines	Meningococcal Reagents
94/532	Pertussis Vaccine (Whole Cell) WHO International Standard	Biotherapeutics	Haemostasis
94/622	Interleukin-13 (Human, rDNA derived) WHO Reference Reagent	Biotherapeutics	Immunoglobulins and Immune Sera
94/674	Thyroid Stimulating Hormone, Human recombinant WHO Reference Reagent	Diagnostics	Quality Control Reagent (D)
94/684	Ciliary Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent	Vaccines	Influenza
94/718	Staphylokinase, rec (STAR)	Diagnostics	Blood Borne Pathogens
94/728	Platelet-derived Growth Factor-BB (Human, rDNA derived) WHO International Standard	Diagnostics	Blood Borne Pathogens
94/730	Tissue Plasminogen Activator (tPA) Antigen in Plasma WHO International Standard	Vaccines	Influenza
94/754	Interferon Omega (Human, rDNA derived) WHO International Standard	Vaccines	Tuberculosis (V)
94/762	Influenza Virus infectious RESVIR-8 (H3N2)	Vaccines	Tuberculosis (V)
94/766	Influenza Virus infectious NIB-34 (H3N2)	Vaccines	Tuberculosis (V)
94/784	Interferon alpha (Human, leukocyte derived)WHO International Standard	Biotherapeutics	Haemostasis
94/786	Interferon alpha Concensus Sequence (Human rDNA derived) WHO International Standard	Diagnostics	Blood Transfusion and Transplantation
94/790	MAPREC analysis of Poliovirus type 3 (Sabin). Synthetic DNA 100 472-C WHO International Standard	Vaccines	Diphtheria
95/510	Influenza Antigen A/Texas/36/91	Diagnostics	Haematinics and Haemoglobin
95/516	Influenza Antigen A/Johannesburg/33/94	Vaccines	Influenza
95/522	Anti-HBc (Anti-hepatitis B core antigen) WHO International Standard	Diagnostics	Immunoglobulins and Immune Sera
95/524	Influenza anti A/Johannesburg/33/94 Serum	Vaccines	Influenza
95/528	Folate, Whole Blood Haemolysate WHO International Standard	Vaccines	Influenza
95/542	MAPREC analysis of Poliovirus type 3 (Sabin) Synthetic DNA 0.9% 472-C WHO International Standard	Vaccines	Influenza
95/544	Interleukin-12 (Human, rDNA derived) WHO Reference Reagent	Vaccines	Influenza
95/554	Interleukin-15 (Human, rDNA derived) WHO Reference Reagent	Vaccines	Influenza
95/564	Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Non-Glyc)	Vaccines	Influenza
95/568	Interferon Alpha n1 (Human lymphoblastoid cell derived) WHO International Standard	Vaccines	Influenza
95/572	Interferon alpha-1/8 (Human, rDNA derived) WHO International Standard	Vaccines	Influenza
95/574	Interferon Alpha n3 (Human, leukocyte derived) WHO International Standard	Diagnostics	Human Papillomavirus
95/580	Interferon alpha-2c (Human, rDNA derived) WHO International Standard	Diagnostics	Human Papillomavirus
95/646	Parathyroid Hormone 1-84, human, recombinant (1st International Standard)	Vaccines	Influenza
95/650	Interferon alpha-2a (Human, rDNA derived) WHO International Standard	Vaccines	Influenza
95/656	Interferon alpha 2b (Human rDNA derived)(3rd International Standard)	Biotherapeutics	Haemostasis
95/668	Single Chain Urinary-Type Plasminogen Activator (SCuPA), (Glyc)	Vaccines	Influenza
95/674	Anti-Meningococcal Serogroup A mAb	Vaccines	Pertussis
95/678	Anti-Meningococcal Serogroup C mAb	Vaccines	Pertussis
96/528	Soluble Tumour Necrosis Factor Receptor Type 1, (Human, rDNA derived)	Vaccines	Pertussis
96/532	FMS-like tyrosine kinase 3 ligand (Human, rDNA derived) WHO Reference Reagent	Vaccines	Pertussis
96/534	Brain-derived Neurotrophic Factor (Human, rDNA derived) WHO Reference Reagent	Vaccines	Influenza
96/538	Insulin-like growth Factor-II (Human rDNA derived) WHO Reference Reagent	Vaccines	Influenza
96/556	Hepatocyte Growth Factor/Scatter Factor (precursor), (Human rDNA derived) WHO International Standard	Vaccines	Influenza
96/564	Hepatocyte Growth Factor/Scatter Factor (Human, rDNA derived) WHO Reference Reagent	Vaccines	Influenza
96/572	MAPREC analysis of Poliovirus type 3 (Sabin) Low virus reference 0.7%472-C WHO Reference Reagent	Vaccines	Meningococcal Reagents
96/578	MAPREC analysis of Poliovirus type 3 (Sabin) High virus reference 1.1%472-C WHO Reference Reagent	Vaccines	Meningococcal Reagents
96/602	Luteinizing Hormone, Human, recombinant WHO International Standard	Biotherapeutics	Haemostasis
96/784	Inhibin B, Human WHO Reference Reagent	Vaccines	Human Papillomavirus
96/836	Influenza Virus infectious RESVIR-9 (H3N2)	Diagnostics	Genomic Reference Material
96/850	Influenza Virus infectious NIB-39 (H1N1)	Biotherapeutics	Haemostasis
97/518	Influenza Antigen A/Johannesburg/82/96	Diagnostics	Blood Transfusion and Transplantation
97/538	Anti-Granulocyte Macrophage Colony Stimulating Factor Serum	Vaccines	Influenza
97/550	Islet Cell Antibodies WHO Reference Reagent	Vaccines	Influenza
97/558	Bordetella pertussis anti 69kD serum (sheep)	Vaccines	Influenza
97/562	Blood Coagulation Factors IXa Concentrate, Human, recombinant(1st I.S.)	Vaccines	Influenza
97/564	Bordetella pertussis anti FHA serum (sheep)	Biotherapeutics	Haemostasis
97/572	Bordetella pertussis PT anti serum (sheep)	Vaccines	Meningococcal Reagents
97/574	Bordetella pertussis anti Fim3 serum (sheep)	Vaccines	Meningococcal Reagents
97/584	Influenza Antigen A/Equine/Newmarket/2/93	Vaccines	Influenza
97/594	Leptin, Human, Recombinant WHO International Standard	Vaccines	Influenza
97/596	Influenza Antigen A/Equine/Newmarket/1/93	Diagnostics	Genomic Reference Material
97/600	Interleukin-2 Soluble Receptor (human, rDNA derived)	Vaccines	Influenza
97/610	Influenza anti A/equine/Newmarket/1/93 Serum	Vaccines	Meningococcal Reagents
97/612	Influenza anti- A/Nanchang/933/95 (H3N2) HA serum	Diagnostics	Parasitology
97/614	Influenza anti A/Equine/Newmarket/2/93 (H3N8) HA Serum (SH-376)	Vaccines	Influenza
97/626	Leptin, Mouse, Recombinant WHO International Standard	Vaccines	Influenza
97/642	Bordetella pertussis anti serum (mouse) 1RR	Biotherapeutics	Cytokines and Growth Factors
97/646	Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard	Vaccines	Influenza
97/648	Anti-Measles serum (3rd International Standard)	Vaccines	Meningococcal Reagents
97/692	Influenza Virus infectious IVR-108 (H3N2)	Diagnostics	Blood Borne Pathogens
97/714	Prolactin, Human, recombinant. WHO Reference Reagent	Vaccines	Influenza
97/722	Influenza Virus infectious A/duck/Sing-Q/119/97 (H5N3)	Vaccines	Influenza
97/748	Influenza Antigen B/Harbin/7/94	Vaccines	Influenza
97/756	MAPREC analysis of Poliovirus type 2 (Sabin), low virus reference 0.65%481-G. WHO Reference Reagent	Vaccines	Meningococcal Reagents
97/758	MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA 0.67%481-G WHO International Standard	Diagnostics	Haemostasis (D)
97/760	Influenza Antigen A/Beijing/262/95	Vaccines	Meningococcal Reagents
98/524	MAPREC analysis of Poliovirus type 2 (Sabin) Synthetic DNA, 100 481-G WHO International Standard	Vaccines	Meningococcal Reagents
98/540	Anti-D	Vaccines	Influenza
98/544	Influenza Virus infectious RESVIR-13 (H3N2)	Vaccines	Influenza
98/572	Diphtheria and Tetanus Antitoxin, Guinea Pig Serum	Vaccines	Meningococcal Reagents
98/574	Somatropin WHO International Standard	Biotherapeutics	Cytokines and Growth Factors
98/580	Prolactin Human, recombinant, glycosylated WHO Reference Reagent	Biotherapeutics	Protein Hormones and Endocrine Products
98/582	Prolactin, Human, recombinant, non-glycosylated WHO Reference Reagent	Diagnostics	Blood Transfusion and Transplantation
98/586	Calcitonin, Salmon. WHO International Standard	Diagnostics	Blood Transfusion and Transplantation
98/596	MAPREC analysis of Poliovirus type 2 (Sabin), high virus reference 1.21% 481-G. WHO Reference Reagent	Vaccines	Meningococcal Reagents
98/600	Influenza Virus infectious NIB-40 (H5N3)	Diagnostics	Haematinics and Haemoglobin
98/604	Influenza anti B/Harbin/7/94/HA Serum	Diagnostics	Blood Transfusion and Transplantation
98/610	Influenza Virus infectious ARIV-1 (H5N3)	Diagnostics	Blood Transfusion and Transplantation
98/666	Influenza anti A/Hong Kong/489/97 (H5N1) Serum (sheep)	Biotherapeutics	Cytokines and Growth Factors
98/686	Negative Control Guinea Pig Serum (Diphtheria and Tetanus Serology)	Biotherapeutics	Cytokines and Growth Factors
98/708	Haemiglobincyanide WHO International Standard	Vaccines	Meningococcal Reagents
98/714	Tissue Plasminogen Activator, Human, Recombinant WHO International Standard	Biotherapeutics	Cytokines and Growth Factors
98/718	Neurotrophin 3	Vaccines	Meningococcal Reagents
98/762	Influenza Virus infectious Resvir-14 (H3N2)	Vaccines	Influenza
98/772	Influenza anti A/Beijing/262/95 Serum	Vaccines	Influenza
98/774	Influenza Antigen B/Shangdong/7/97	Diagnostics	Blood Borne Pathogens
98/778	Influenza Virus infectious A/Sichuan/346/98 (H3N2)	Diagnostics	Haemostasis (D)
99/506	Anti-PT S1 subunit Monoclonal Antibody (1B7)	Vaccines	Influenza
99/508	Anti-PT S1 subunit Monoclonal Antibody (1D7)	Vaccines	Influenza
99/510	Anti-PT S1 subunit Monoclonal Antibody (3F11)	Vaccines	Meningococcal Reagents
99/512	Anti-PT S1 subunit Monoclonal Antibody (10D6)	Vaccines	Botulinum
99/514	Anti-PT S1 subunit Monoclonal Antibody (8G4)	Vaccines	Meningococcal Reagents
99/516	Anti-PT S1 subunit Monoclonal Antibody (E1E)	Vaccines	Meningococcal Reagents
99/518	Anti-PT S1 subunit Monoclonal Antibody (E2E)	Vaccines	Influenza
99/520	Anti-PT S1 subunit Monoclonal Antibody (3F10)	Vaccines	Tetanus
99/522	Anti-PT S1 subunit Monoclonal Antibody (11D9)	Biotherapeutics	Immunoglobulins and Immune Sera
99/524	Anti-PT S1 subunit Monoclonal Antibody (4D10)	Biotherapeutics	Immunoglobulins and Immune Sera
99/526	Anti-PT S23 subunit Monoclonal Antibody (11E6)	Biotherapeutics	Immunoglobulins and Immune Sera
99/528	Anti-PT S23 subunit Monoclonal Antibody (10C9)	Diagnostics	Blood Borne Pathogens
99/530	Anti-PT S23 subunit Monoclonal Antibody (10B5)	Vaccines	Japanese Encephalitis
99/532	Anti-PT S23 subunit Monoclonal Antibody (G9A)	Vaccines	Japanese Encephalitis
99/534	Anti-PT S23 subunit Monoclonal Antibody (3F6)	Vaccines	Meningococcal Reagents
99/536	Anti-PT S2 subunit Monoclonal Antibody (3A12)	Vaccines	Meningococcal Reagents
99/538	Anti-PT S2 subunit Monoclonal Antibody (2H3)	Vaccines	Meningococcal Reagents
99/540	Anti-PT S2 subunit Monoclonal Antibody (9G8)	Vaccines	Meningococcal Reagents
99/542	Anti-PT S3 subunit Monoclonal Antibody (7E10)	Vaccines	Influenza
99/544	Anti-PT S3 subunit Monoclonal Antibody (7G11)	Vaccines	Influenza
99/546	Anti-PT S3 subunit Monoclonal Antibody (4G5)	Vaccines	Influenza
99/548	Anti-PT S3 subunit Monoclonal Antibody (2E12)	Diagnostics	Parvovirus
99/550	Anti-PT S3 subunit Monoclonal Antibody (6F8)	Diagnostics	Parasitology
99/552	Anti-PT S3 subunit Monoclonal Antibody (10B8)	Vaccines	Influenza
99/554	Anti-PT S4 subunit Monoclonal Antibody (7F2)	Vaccines	Meningococcal Reagents
99/556	Anti-PT S4 subunit Monoclonal Antibody (6B3)	Vaccines	Meningococcal Reagents
99/558	Anti-PT S4 subunit Monoclonal Antibody (6G8)	Vaccines	Botulinum
99/560	Anti-PT S4 subunit Monoclonal Antibody (9F3)	Vaccines	Botulinum
99/562	Anti-PT S4 subunit Monoclonal Antibody (1H2)	Vaccines	Botulinum
99/564	Anti-PT S4 subunit Monoclonal Antibody (9C6)	Vaccines	Botulinum
99/566	Anti-PT S4 subunit Monoclonal Antibody (6D6)	Vaccines	Influenza
99/568	Anti-PT S5 subunit Monoclonal Antibody (7E3)	Vaccines	Influenza
99/570	Anti Filamentous Haemagglutinin Monoclonal Antibody (1C6)	Biotherapeutics	Cytokines and Growth Factors
99/572	Anti-Filamentous Haemagglutinin Monoclonal Antibody (2E9)	Vaccines	Meningococcal Reagents
99/574	Anti Filamentous Haemagglutinin Monoclonal Antibody (12G10)	Vaccines	Pneumococcal vaccines
99/586	Influenza Antigen B/Yamanashi/166/98	Biotherapeutics	Cytokines and Growth Factors
99/614	Influenza Antigen A/Sydney/5/97	Biotherapeutics	Cytokines and Growth Factors
99/616	Yellow Fever Vaccine. WHO International Standard	Biotherapeutics	Cytokines and Growth Factors
99/624	Influenza Antigen A/Sydney/5/97	Vaccines	Influenza
99/642	Chorionic Gonadotrophin, nicked, human. WHO Reference Reagent	Vaccines	Influenza
99/650	Chorionic Gonadotrophin, beta subunit, human. WHO Reference Reagent	Vaccines	Influenza
99/666	Anti-HPA-5b (Minimum Potency) WHO Reference Reagent	Vaccines	Influenza
99/674	HIV-2 (antibody) Monitor Sample	Vaccines	Influenza
99/688	Chorionic Gonadatrophin, intact, Human. WHO Reference Reagent	Vaccines	Botulinum
99/692	Chorionic Gonadotrophin, nicked beta subunit, Human WHO Reference Reagent	Vaccines	Diphtheria
99/706	Anti-Meningococcal human reference serum CDC1992	Vaccines	Influenza
99/708	Chorionic Gonadatrophin, beta core fragment, Human WHO Reference Reagent	Vaccines	Influenza
99/710	Anti-HIV 1 (1 in 5 BWS)	Vaccines	Influenza
99/710	Anti-HIV 1 (1 in 5 BWS)	Vaccines	Polio
99/720	Chorionic Gonadotrophin, alpha subunit, Human (purified)	Vaccines	Polio
99/750	British Working Standard for Anti-HIV 1	Vaccines	Polio
99/824	Influenza Virus infectious RESVIR 16 (H3N2)	Vaccines	Polio
99/828	Influenza Antigen B/Yamanashi/166/98	Vaccines	Polio
99/836	Anti-D Minimum Potency Standard for blood grouping reagents WHO International Standard	Diagnostics	Coronavirus (D)
AFP	Alpha-Foetoprotein. WHO International Standard	Vaccines	Coronavirus (V)
BUSB	Botulinum Antitoxin Equine Type B. WHO International Standard	Diagnostics	Coronavirus (D)
CDS	Anti-Canine Distemper Serum. WHO International Standard	Vaccines	Coronavirus (V)
CHAN	Cholera Antitoxin, Goat. WHO International Standard	Diagnostics	Coronavirus (D)
CHS	Anti-Canine Hepatitis Serum	Vaccines	Coronavirus (V)
COT	Clostridium novyi (alpha) Toxoid. WHO Reference Reagent	Diagnostics	Coronavirus (D)
CWBETATD	Clostridium Welchii (Perfringens)(Beta) Toxoid CwBT WHO Reference Reagent	Vaccines	Coronavirus (V)
CWEPSILTD	Clostridium Welchii (Perfringens) (Epsilon) toxoid	Diagnostics	Coronavirus (D)
DIM9	Diphtheria toxoid monoclonal antibody, clone Dim9	Vaccines	Coronavirus (V)
DT05	Diphtheria toxoid monoclonal antibody, clone DT05	Diagnostics	Coronavirus (D)
DY	Anti-Dysentery (shiga) serum, Equine. WHO International Standard	Vaccines	Coronavirus (V)
FHADETOX/6	Filamentous Haemagglutinin monoclonal antibody, clone FHADETOX/6	Diagnostics	Coronavirus (D)
G10F8C3	Fimbrae monoclonal antibody, clone G10F8C3	Vaccines	Coronavirus (V)
HBOHA	Lyophilised HBO-HA Antigen for ELISA, Lot 17	Diagnostics	Coronavirus (D)
JNIH-11	Bordetella pertussis anti FHA serum (mouse)	Vaccines	Coronavirus (V)
JNIH-12	Bordetella pertussis PT( LPF) anti serum, (mouse)	Diagnostics	Coronavirus (D)
JNIH-3	Acellular Pertussis Vaccine - 1st IS.	Vaccines	Coronavirus (V)
JNIH-4	Bordetella pertussis filamentous haemagglutinin (FHA)	Diagnostics	Coronavirus (D)
MEF/001	Primary Mouse Embryo Fibroblasts (p0)	Vaccines	Coronavirus (V)
MGDS	Anti-Mycoplasma gallisepticum Serum. WHO Reference Reagent	Diagnostics	Coronavirus (D)
NDS	Anti-Newcastle Disease Serum. WHO International Standard	Vaccines	Coronavirus (V)
NVIA	Newcastle Disease Vaccine (Inactivated) WHO International Standard	Diagnostics	Coronavirus (D)
OE	Gas Gangrene Antitoxin (Cl. novyi), Equine WHO International Standard	Vaccines	Coronavirus (V)
PE	Gas Gangrene Antitoxin (Cl. Perfringens alpha antitoxin) Equine WHO International Standard	Diagnostics	Coronavirus (D)
PPDBOV	Purified Protein Derivative (PPD) of Mycobacterium bovis Tuberculin (WHO 1st International Standard)	Vaccines	Coronavirus (V)
PPDT	Purified Protein Derivative (PPD) of M. Tuberculosis Tuberculin WHO International Standard	Diagnostics	Coronavirus (D)
PS21C2.2.1	Pertussis toxoid monoclonal antibody, clone PS21C2.2.1	Vaccines	Coronavirus (V)
QCRCMVIgMQC1	QCRCMVIgMQC1 IgM Anti-CMV QC1	Diagnostics	Coronavirus (D)
QCRCMVQC1	Anti CMV QC1 QCRCMVQC1	Vaccines	Coronavirus (V)
QCREBVIgMQC1	QCREBVIgMQC1	Diagnostics	Coronavirus (D)
QCREBVVCAQC1	QCREBVVCAQC1	Vaccines	Coronavirus (V)
QCRFERRQC1	Ferritin Quality Control Sample	Diagnostics	Coronavirus (D)
QCRHAVIgMQC2	QCRHAVIgMQC2 IgM Anti-HAV Quality Control Serum: Sample2	Vaccines	Coronavirus (V)
QCRHBCIGMQC1	QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1	Diagnostics	Coronavirus (D)
QCRHBeQC1	QCRHBeQC1 Anti-HBe Control Serum: sample1	Vaccines	Coronavirus (V)
QCRHBsGQC1	QCRHBsGQC1-HBsAg Quality Control Serum: Sample1	Diagnostics	Coronavirus (D)
QCRHBsGQC2	QCRHBsGQC2-Anti HBsAg Quality Control Serum: Sample2	Vaccines	Coronavirus (V)
QCRHBsQC1	QCRHBsQC1	Diagnostics	Coronavirus (D)
QCRHCVQC1	QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1	Vaccines	Coronavirus (V)
QCRHEVIgMQC1	QCRHEVIgMQC1 - IgM Anti-Hepatitis E Quality Control Sample 1	Diagnostics	Coronavirus (D)
QCRHEVQC1	QCRHEVQC1 - Anti-Hepatitis E Quality Control Sample 1	Vaccines	Coronavirus (V)
QCRHIV1P24QC1	QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1	Diagnostics	Coronavirus (D)
QCRHIV1p24QC2	QCRHIV1p24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2	Vaccines	Coronavirus (V)
QCRHIV1QC1	QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1	Diagnostics	Coronavirus (D)
QCRHIV1QC2	QCRHIV1QC2 - Anti-HIV Quality Control Serum sample 2	Vaccines	Coronavirus (V)
QCRHIV1QC3	QCRHIV1QC3-Anti-HIV1:Quality Control Serum:Sample 3	Diagnostics	Coronavirus (D)
QCRHIV1QC5	QCRHIV1QC5 - Anti-HIV-1 Quality Control Reagent Sample 5	Vaccines	Coronavirus (V)
QCRHIV1RTDQC1	QCRHIV1RTDQC1- Anti-HIV1 Quality Control Serum: Sample 1 for Rapid Test Devices	Diagnostics	Coronavirus (D)
QCRHIV2QC2	QCRHIV2QC2-Anti HIV2: Quality Control Serum: Sample2	Vaccines	Coronavirus (V)
QCRHIV2QC3	QCRHIV2QC3- Anti HIV2: Quality Control Serum: Sample 3	Diagnostics	Coronavirus (D)
QCRHIV2QC4	QCRHIV2QC4 - Anti HIV2 Quality Control Serum Sample 4	Vaccines	Coronavirus (V)
QCRHSV1QC1	QCRHSV1QC1-Anti-HSV1 Quality Control Serum: Sample1	Diagnostics	Coronavirus (D)
QCRHSV2QC1	QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample 1	Vaccines	Coronavirus (V)
QCRLYMEIgMQC1	QCRLYMEIgMQC1 IgM Anti-Lyme QC1	Diagnostics	Coronavirus (D)
QCRLYMEQC1	QCRLYMEQC1 - Anti-Lyme QC1	Vaccines	Coronavirus (V)
QCRMALQC1	QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1	Diagnostics	Coronavirus (D)
QCRMEASQC1	QCRMEASQC1 Anti-Measles QC1	Vaccines	Coronavirus (V)
QCRMUMPSQC1	QCRMUMPSQC1 - Anti-Mumps Quality Control Reagent Sample 1	Diagnostics	Coronavirus (D)
QCRNEGQC1	QCRNEGQC1-Negative Quality Control Serum: Sample1	Vaccines	Coronavirus (V)
QCRPARVB19IgMQC1	QCRPARVB19IgMQC1 - IgM Anti-Parvovirus B19 Quality Control Reagent 1	Diagnostics	Coronavirus (D)
QCRPARVB19QC1	QCRPARVB19QC1 Anti-Parvovirus B19QC1	Vaccines	Coronavirus (V)
QCRRUBIgMQC1	QCRRUBIgMQC1-Anti-Rubella IgM Quality Control Serum: Sample 1	Diagnostics	Coronavirus (D)
QCRRUBQC1	QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample 1	Vaccines	Coronavirus (V)
QCRRUBQC2	Anti-Rubella QC2	Diagnostics	Coronavirus (D)
QCRSARSCOV-2QC1	QCRSARSCoV2QC1	Vaccines	Coronavirus (V)
QCRSYPHQC1	QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1	Diagnostics	Coronavirus (D)
QCRTHAVQC1	QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1	Vaccines	Coronavirus (V)
QCRTHBcQC1	QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1	Diagnostics	Coronavirus (D)
QCRTHBcQC2	QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2	Vaccines	Coronavirus (V)
QCRTOXOIgMQC1	QCRTOXOIgMQC1 IgM Anti-Toxoplasma QC1	Diagnostics	Coronavirus (D)
QCRTOXOQC1	QCRTOXOQC1 - Anti-Toxoplasma gondii Quality Control Reagent Sample 1	Vaccines	Coronavirus (V)
QCRVZVQC1	QCRVZVQC1-Anti VZV: Quality Control Serum: Sample 1	Diagnostics	Coronavirus (D)
QF	Anti-Q Fever Serum, Bovine WHO International Standard	Vaccines	Coronavirus (V)
RBT/16	Thromboplastin, Rabbit, Plain 5th International Standard 2016.	Diagnostics	Coronavirus (D)
RBT/16	Thromboplastin, Rabbit, Plain 5th International Standard 2016.	Vaccines	Coronavirus (V)
RTF/16	Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016.	Diagnostics	Coronavirus (D)
RTF/16	Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016.	Vaccines	Coronavirus (V)
RUBI-1-94	Anti-rubella Immunoglobulin, Human WHO International Standard	Diagnostics	Coronavirus (D)
SES	Swine Erysipelas Serum (anti-N) WHO Reference Reagent	Vaccines	Coronavirus (V)
SFS	Anti-Swine Fever Serum WHO International Standard	Diagnostics	Coronavirus (D)
SMV	Smallpox Vaccine WHO International Standard	Vaccines	Coronavirus (V)
SPDS-S2	Anti-Salmonella Pullorum Serum (Std. Form S) WHO International Standard	Diagnostics	Coronavirus (D)
SPDS-V	Anti-Salmonella Pullorum Serum (Variant Form V) WHO International Standard	Vaccines	Coronavirus (V)
SPLS	Anti-Staphylococcal P-V Leucocidin serum, Equine WHO Reference Reagent	Diagnostics	Coronavirus (D)
SS-319/20	FITC CD4 Positive Control Cells	Vaccines	Coronavirus (V)
SSCLOT5	SSC Secondary Coagulation Standard Lot#5	Diagnostics	Coronavirus (D)
STA	Staphylococcus Alpha Antitoxin, Equine WHO International Standard	Vaccines	Coronavirus (V)
STT	Diphtheria (Schick) Test Toxin WHO International Standard	Diagnostics	Coronavirus (D)
TILI	Anti-tick borne encephalitis serum (Louping Ill) WHO International Standard	Vaccines	Coronavirus (V)
TISA	Anti-tick borne encephalitis serum (Sophyn & Absettarov) WHO International Standard	Diagnostics	Coronavirus (D)
TT010	Tetanus toxoid monoclonal antibody, clone TT010	Vaccines	Coronavirus (V)
TYVK	Typhoid Vaccine (acetone-inactivated) WHO International Standard	Diagnostics	Coronavirus (D)
TYVL	Typhoid Vaccine (heat-phenol-inactivated) WHO International Standard	Vaccines	Coronavirus (V)
VI	Gas Gangrene Antitoxin (Cl. Septicum), Equine WHO International Standard	Vaccines	Pertussis
W1004	Anti-C complete blood typing serum,human WHO International Standard	Vaccines	Pertussis
W1005	Anti-E complete blood typing serum, human WHO International Standard	Vaccines	Pertussis
W1007	Anti-c Incomplete blood typing serum, human WHO International Standard	Vaccines	Polio
W1062	Anti smooth muscle(anti actin) autoantibody. WHO Reference Reagent	Diagnostics	Coronavirus (D)
W1063	Anti nuclear ribonucleoprotein(nRNP) autoantibody WHO Reference Reagent	Vaccines	Coronavirus (V)
W1064	Anti-Nuclear factor serum,homogenous(66/233)	Vaccines	Polio
YF	Anti-Yellow Fever Serum, monkey WHO Reference Reagent	Vaccines	Polio

產(chǎn)品咨詢

留言框

產(chǎn)品：
您的單位：
您的姓名：
聯(lián)系電話：
常用郵箱：
省份：
詳細(xì)地址：
補(bǔ)充說明：
驗(yàn)證碼：

請輸入計(jì)算結(jié)果（填寫阿拉伯?dāng)?shù)字），如：三加四=7

上一篇：中檢院標(biāo)準(zhǔn)品
下一篇：PEI國際標(biāo)準(zhǔn)品

欧美澳门日本三级做爰,啊啊啊用力好舒服视频,91精品国产白丝在线观看,久久亚洲国产精品成人

留言框

產(chǎn)品：

您的單位：

您的姓名：

聯(lián)系電話：

常用郵箱：

省份：

詳細(xì)地址：

補(bǔ)充說明：

驗(yàn)證碼：